1
|
Dezordi FZ, Júnior JVJS, Ruoso TF, Batista AG, Fonseca PM, Bernardo LP, Salvato RS, Gregianini TS, Lopes TRR, Flores EF, Weiblen R, Brites PC, Silva MDM, da Rocha JBT, Barbosa GDL, Machado LC, da Silva AF, Paiva MHS, Bezerra MF, Campos TDL, Gräf T, Graichen DAS, Loreto ELDS, Wallau GDL. Higher frequency of interstate over international transmission chains of SARS-CoV-2 virus at the Rio Grande do Sul - Brazil state borders. Virus Res 2024; 351:199500. [PMID: 39645167 DOI: 10.1016/j.virusres.2024.199500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2024] [Revised: 09/20/2024] [Accepted: 11/14/2024] [Indexed: 12/09/2024]
Abstract
Brazil's COVID-19 response has faced challenges due to the continuous emergence of variants of concern (VOCs), emphasizing the need for ongoing genomic surveillance and retrospective analyses of past epidemic waves to reassess and fine tune containment protocols. Rio Grande do Sul (RS), Brazil's southernmost state, has international borders and trades with Argentina and Uruguay, along with significant domestic connections within Brazil. The identification of source and sink transmission chains at national and international scales can identify main hubs and pathways to target future interventions. In this study we investigated the RS state role in the national and international SARS-CoV-2 transmission chains, which has not been fully explored. Nasopharyngeal samples from various municipalities in RS were collected between June 2020 and July 2022. SARS-CoV-2 whole genome amplification and sequencing were performed using high-throughput Illumina sequencing. Bioinformatics analysis encompassed the development of scripts and tools to perform subsampling taking into account epidemiological information to reduce sequencing disparities bias among the regions/countries, genome assembly, and large-scale alignment and phylogenetic reconstruction. We sequenced a total of 1,480 SARS-CoV-2 genomes from RS, covering all major regions. Sequences predominantly represented Gamma (April-June 2021) and Omicron (January-July 2022) lineages. Phylogenetic analysis revealed a regional pattern for transmission dynamics, particularly with Southeast Brazil for Gamma, and a range of inter-regional connections for Delta and Omicron within the country. On the other hand, international and cross-border transmission with Argentina and Uruguay was rather limited. We evaluated the three VOCs circulation over two years in RS using a new subsampling strategy based on the number of cases in each state during the circulation of each VOC. In summary, the retrospective analysis of genomic surveillance data demonstrated that virus transmission was less intense between country borders than within the country. These findings suggest that while non-pharmacological interventions were effective to mitigate transmission across international RS land borders, they were insufficient to contain transmission at the domestic level.
Collapse
Affiliation(s)
- Filipe Zimmer Dezordi
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife Pernambuco, 50670-420, Brazil; Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, 50670-420, Brazil
| | - José Valter Joaquim Silva Júnior
- Setor de Virologia, Departamento de Medicina Veterinária Preventiva, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, 97105-900, Brazil; Setor de Virologia, Instituto Keizo Asami, Universidade Federal de Pernambuco, Pernambuco, 50670-901, Brazil; Laboratório NB3 de Neuroimunologia, Universidade Federal de Santa Maria, Rio Grande do Sul, 97105-900, Brazil; Departamento de Microbiologia e Parasitologia, Universidade Federal de Santa Maria, Rio Grande do Sul, 97105-900, Brazil; Programa de Pós-graduação em Medicina Veterinária, Universidade Federal de Santa Maria, Rio Grande do Sul, 97105-900, Brazil; Programa de Pós-graduação em Farmacologia, Universidade Federal de Santa Maria, Rio Grande do Sul, Brazil
| | - Terimar Facin Ruoso
- Campus Palmeira das Missões, Universidade Federal de Santa Maria. Palmeira das Missões, Rio Grande do Sul, 98300-000, Brazil
| | - Angela Giovana Batista
- Campus Palmeira das Missões, Universidade Federal de Santa Maria. Palmeira das Missões, Rio Grande do Sul, 98300-000, Brazil; Life Sciences Institute, Universidade Federal de Juiz de Fora. Governador Valadares, Minas Gerais, 35010-180, Brazil
| | - Pedro Mesquita Fonseca
- Campus Palmeira das Missões, Universidade Federal de Santa Maria. Palmeira das Missões, Rio Grande do Sul, 98300-000, Brazil
| | - Larissa Paim Bernardo
- Departamento de Ciências da Vida - DCVIDA, Universidade Regional do Noroeste do Estado do Rio Grande do Sul - UNIJUÍ, Ijuí, Rio Grande do Sul, 98700-000, Brazil
| | - Richard Steiner Salvato
- Centro Estadual de Vigilância em Saúde. Secretaria Estadual da Saúde do Rio Grande do Sul. Porto Alegre, Rio Grande do Sul, 90610-000, Brazil
| | - Tatiana Schäffer Gregianini
- Centro Estadual de Vigilância em Saúde. Secretaria Estadual da Saúde do Rio Grande do Sul. Porto Alegre, Rio Grande do Sul, 90610-000, Brazil
| | - Thaísa Regina Rocha Lopes
- Setor de Virologia, Departamento de Medicina Veterinária Preventiva, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, 97105-900, Brazil; Programa de Pós-graduação em Medicina Veterinária, Universidade Federal de Santa Maria, Rio Grande do Sul, 97105-900, Brazil
| | - Eduardo Furtado Flores
- Setor de Virologia, Departamento de Medicina Veterinária Preventiva, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, 97105-900, Brazil
| | - Rudi Weiblen
- Setor de Virologia, Departamento de Medicina Veterinária Preventiva, Universidade Federal de Santa Maria (UFSM), Santa Maria, Rio Grande do Sul, 97105-900, Brazil
| | - Patrícia Chaves Brites
- Hospital Universitário de Santa Maria (HUSM), Universidade Federal de Santa Maria (UFSM), Av. Roraima, 1000, Santa Maria, Rio Grande do Sul, 97105-900, Brazil
| | - Mônica de Medeiros Silva
- Departamento de Bioquímica e Biologia Molecular, Universidade Federal de Santa Maria (UFSM), Av. Roraima, 1000, Santa Maria, Rio Grande do Sul, 97105-900, Brazil
| | - João Batista Teixeira da Rocha
- Departamento de Bioquímica e Biologia Molecular, Universidade Federal de Santa Maria (UFSM), Av. Roraima, 1000, Santa Maria, Rio Grande do Sul, 97105-900, Brazil
| | - Gustavo de Lima Barbosa
- Núcleo de Plataformas Tecnológicas (NPT), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, 50670-420, Brazil
| | - Lais Ceschini Machado
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife Pernambuco, 50670-420, Brazil
| | - Alexandre Freitas da Silva
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife Pernambuco, 50670-420, Brazil; Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, 50670-420, Brazil
| | - Marcelo Henrique Santos Paiva
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife Pernambuco, 50670-420, Brazil; Núcleo de Ciências da Vida, Universidade Federal de Pernambuco (UFPE), Centro Acadêmico do Agreste-Rodovia BR-104, Caruaru, Pernambuco, 55002-970, Brazil
| | - Matheus Filgueira Bezerra
- Departamento de Microbiologia, Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, 50670-420, Brazil
| | - Tulio de Lima Campos
- Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, 50670-420, Brazil
| | - Tiago Gräf
- Laboratório de Virologia Molecular, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba, Paraná, Brazil
| | - Daniel Angelo Sganzerla Graichen
- Departamento de Zootecnia e Ciências Biológicas, Universidade Federal de Santa Maria, Palmera das Missões, Rio Grande do Sul 98300-000, Brazil
| | - Elgion Lucio da Silva Loreto
- Hospital Universitário de Santa Maria (HUSM), Universidade Federal de Santa Maria (UFSM), Av. Roraima, 1000, Santa Maria, Rio Grande do Sul, 97105-900, Brazil
| | - Gabriel da Luz Wallau
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife Pernambuco, 50670-420, Brazil; Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, 50670-420, Brazil; Department of Arbovirology and Entomology, Bernhard Nocht Institute for Tropical Medicine, WHO Collaborating Center for Arbovirus and Hemorrhagic Fever Reference and Research. National Reference Center for Tropical Infectious Diseases. Bernhard-Nocht-Straße 74 20359 Hamburg, Germany.
| |
Collapse
|
2
|
Cella E, Fonseca V, Branda F, Tosta S, Moreno K, Schuab G, Ali S, Slavov SN, Scarpa F, Santos LA, Kashima S, Wilkinson E, Tegally H, Mavian C, Borsetti A, Caccuri F, Salemi M, de Oliveira T, Azarian T, de Filippis AMB, Alcantara LCJ, Ceccarelli G, Caruso A, Colizzi V, Marcello A, Lourenço J, Ciccozzi M, Giovanetti M. Integrated analyses of the transmission history of SARS-CoV-2 and its association with molecular evolution of the virus underlining the pandemic outbreaks in Italy, 2019-2023. Int J Infect Dis 2024; 149:107262. [PMID: 39389289 DOI: 10.1016/j.ijid.2024.107262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2024] [Revised: 10/01/2024] [Accepted: 10/02/2024] [Indexed: 10/12/2024] Open
Abstract
BACKGROUND Italy was significantly affected by the COVID-19 pandemic, experiencing multiple waves of infection following the sequential emergence of new variants. Understanding the transmission patterns and evolution of SARS-CoV-2 is vital for future preparedness. METHODS We conducted an analysis of viral genome sequences, integrating epidemiological and phylodynamic approaches, to characterize how SARS-CoV-2 variants have spread within the country. RESULTS Our findings indicate bidirectional international transmission, with Italy transitioning between importing and exporting the virus. Italy experienced four distinct epidemic waves, each associated with a significant reduction in fatalities from 2021 to 2023. These waves were primarily driven by the emergence of VOCs such as Alpha, Delta, and Omicron, which were reflected in observed transmission dynamics and effectiveness of public health measures. CONCLUSIONS The changing patterns of viral spread and variant prevalence throughout Italy's pandemic response underscore the continued importance of flexible public health strategies and genomic surveillance, both of which are crucial for tracking the evolution of variants and adapting control measures effectively to ensure preparedness for future outbreaks.
Collapse
Affiliation(s)
- Eleonora Cella
- Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA
| | - Vagner Fonseca
- Department of Exact and Earth Sciences, University of the State of Bahia, Salvador, Brazil
| | - Francesco Branda
- Unit of Medical Statistics and Molecular Epidemiology, University of Campus Bio-Medico di Roma, Rome, Italy
| | - Stephane Tosta
- Programa Interunidades de Pós-Graduação em Bioinformática, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Keldenn Moreno
- Programa Interunidades de Pós-Graduação em Bioinformática, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Gabriel Schuab
- Laboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil
| | - Sobur Ali
- Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA
| | - Svetoslav Nanev Slavov
- Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil; Butantan Institute, São Paulo, Brazil
| | - Fabio Scarpa
- Department of Biomedical Sciences, University of Sassari, Sassari, Italy
| | | | - Simone Kashima
- Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - Eduan Wilkinson
- Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
| | - Houriiyah Tegally
- Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
| | - Carla Mavian
- Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA; Global Health Program Smithsonian's National Zoo & Conservation Biology Institute, DC, USA
| | - Alessandra Borsetti
- National HIV/AIDS Research Center (CNAIDS), Istituto Superiore di Sanità, Rome, Italy
| | - Francesca Caccuri
- Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia, Brescia, Italy
| | - Marco Salemi
- Department of Pathology, Immunology and Laboratory Medicine, College of Medicine, Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
| | - Tulio de Oliveira
- Centre for Epidemic Response and Innovation (CERI), School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa
| | - Taj Azarian
- Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL, USA
| | - Ana Maria Bispo de Filippis
- Laboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil
| | | | - Giancarlo Ceccarelli
- Infectious Diseases Department, Azienda Ospedaliero Universitaria Policlinico Umberto I, Rome, Italy
| | - Arnaldo Caruso
- Department of Molecular and Translational Medicine, Section of Microbiology, University of Brescia, Brescia, Italy
| | - Vittorio Colizzi
- UNESCO Chair of Interdisciplinary Biotechnology and Bioethics, University of Rome Tor Vergata, Rome, Italy
| | - Alessandro Marcello
- Laboratory of Molecular Virology, International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy
| | - José Lourenço
- Faculdade de Medicina, Biomedical Research Center, Universidade Católica Portuguesa, Lisboa, Portugal
| | - Massimo Ciccozzi
- Unit of Medical Statistics and Molecular Epidemiology, University of Campus Bio-Medico di Roma, Rome, Italy
| | - Marta Giovanetti
- Department of Sciences and Technologies for Sustainable Development and One Health, Universita Campus Bio-Medico di Roma, Rome, Italy; Oswaldo Cruz Foundation, Oswaldo Cruz Institute, Rio de Janeiro, Brazil.
| |
Collapse
|
3
|
Carnegie L, McCrone JT, du Plessis L, Hasan M, Ali MZ, Begum R, Hassan MZ, Islam S, Rahman MH, Uddin ASM, Sarker MS, Das T, Hossain M, Khan M, Razu MH, Akram A, Arina S, Hoque E, Molla MMA, Nafisaa T, Angra P, Rambaut A, Pullan ST, Osman KL, Hoque MA, Biswas P, Flora MS, Raghwani J, Fournié G, Samad MA, Hill SC. Genomic epidemiology of early SARS-CoV-2 transmission dynamics in Bangladesh. Virol J 2024; 21:291. [PMID: 39538264 PMCID: PMC11562509 DOI: 10.1186/s12985-024-02560-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/12/2024] [Accepted: 10/26/2024] [Indexed: 11/16/2024] Open
Abstract
BACKGROUND Genomic epidemiology has helped reconstruct the global and regional movement of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). However, there is still a lack of understanding of SARS-CoV-2 spread in some of the world's least developed countries (LDCs). METHODS To begin to address this disparity, we studied the transmission dynamics of the virus in Bangladesh during the country's first COVID-19 wave by analysing case reports and whole-genome sequences from all eight divisions of the country. RESULTS We detected > 50 virus introductions to the country during the period, including during a period of national lockdown. Additionally, through discrete phylogeographic analyses, we identified that geographical distance and population -density and/or -size influenced virus spatial dispersal in Bangladesh. CONCLUSIONS Overall, this study expands our knowledge of SARS-CoV-2 genomic epidemiology in Bangladesh, shedding light on crucial transmission characteristics within the country, while also acknowledging resemblances and differences to patterns observed in other nations.
Collapse
Affiliation(s)
- L Carnegie
- Department of Pathobiology and Population Sciences, Royal Veterinary College (RVC), Hatfield, Hertfordshire, UK.
| | - J T McCrone
- Institute of Ecology and Evolution, University of Edinburgh, King's Buildings, Edinburgh, UK
- Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
| | - L du Plessis
- Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland
- Swiss Institute of Bioinformatics, Lausanne, Switzerland
| | - M Hasan
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - M Z Ali
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - R Begum
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - M Z Hassan
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - S Islam
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
- Global Change Center, Virginia Tech, Blacksburg, VA, USA
| | - M H Rahman
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - A S M Uddin
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - M S Sarker
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh
| | - T Das
- Chattogram Veterinary and Animal Sciences University (CVASU), Khulshi, Chattogram, Bangladesh
- School of Agricultural, Environmental and Veterinary Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia
| | - M Hossain
- NSU Genome Research Institute (NGRI), North South University, Bashundhara, Dhaka, Bangladesh
- Department of Biochemistry and Microbiology, North South University, Bashundhara, Dhaka, Bangladesh
| | - M Khan
- Bangladesh Reference Institute for Chemical Measurements (BRiCM), Dhanmondi, Dhaka, Bangladesh
| | - M H Razu
- Bangladesh Reference Institute for Chemical Measurements (BRiCM), Dhanmondi, Dhaka, Bangladesh
| | - A Akram
- National Institute of Laboratory Medicine and Referral Centre (NILMRC), Agargoan, Dhaka, Bangladesh
| | - S Arina
- National Institute of Laboratory Medicine and Referral Centre (NILMRC), Agargoan, Dhaka, Bangladesh
| | - E Hoque
- National Institute of Laboratory Medicine and Referral Centre (NILMRC), Agargoan, Dhaka, Bangladesh
| | - M M A Molla
- National Institute of Laboratory Medicine and Referral Centre (NILMRC), Agargoan, Dhaka, Bangladesh
| | - T Nafisaa
- National Institute of Laboratory Medicine and Referral Centre (NILMRC), Agargoan, Dhaka, Bangladesh
| | - P Angra
- Centers for Disease Control and Prevention (CDC), Atlanta, GA, USA
| | - A Rambaut
- Institute of Ecology and Evolution, University of Edinburgh, King's Buildings, Edinburgh, UK
| | - S T Pullan
- United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury, UK
| | - K L Osman
- United Kingdom Health Security Agency (UKHSA), Porton Down, Salisbury, UK
| | - M A Hoque
- Chattogram Veterinary and Animal Sciences University (CVASU), Khulshi, Chattogram, Bangladesh
| | - P Biswas
- Chattogram Veterinary and Animal Sciences University (CVASU), Khulshi, Chattogram, Bangladesh
| | - M S Flora
- National Institute of Preventive and Social Medicine (NIPSOM), Ministry of Health and Family Welfare, Dhaka, Bangladesh
| | - J Raghwani
- Department of Pathobiology and Population Sciences, Royal Veterinary College (RVC), Hatfield, Hertfordshire, UK
| | - G Fournié
- Department of Pathobiology and Population Sciences, Royal Veterinary College (RVC), Hatfield, Hertfordshire, UK
- Université de Lyon, INRAE, VetAgro Sup, UMR EPIA, Marcy l'Etoile, France
- Université Clermont Auvergne, INRAE, VetAgro Sup, UMR EPIA, Saint Genes Champanelle, France
| | - M A Samad
- Bangladesh Livestock Research Institute (BLRI), Savar, Dhaka, Bangladesh.
| | - S C Hill
- Department of Pathobiology and Population Sciences, Royal Veterinary College (RVC), Hatfield, Hertfordshire, UK.
| |
Collapse
|
4
|
Gutierrez B, Tsui JLH, Pullano G, Mazzoli M, Gangavarapu K, Inward RPD, Bajaj S, Evans Pena R, Busch-Moreno S, Suchard MA, Pybus OG, Dunner A, Puentes R, Ayala S, Fernandez J, Araos R, Ferres L, Colizza V, Kraemer MUG. Routes of importation and spatial dynamics of SARS-CoV-2 variants during localized interventions in Chile. PNAS NEXUS 2024; 3:pgae483. [PMID: 39525554 PMCID: PMC11547135 DOI: 10.1093/pnasnexus/pgae483] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Accepted: 08/27/2024] [Indexed: 11/16/2024]
Abstract
Human mobility is strongly associated with the spread of SARS-CoV-2 via air travel on an international scale and with population mixing and the number of people moving between locations on a local scale. However, these conclusions are drawn mostly from observations in the context of the global north where international and domestic connectivity is heavily influenced by the air travel network; scenarios where land-based mobility can also dominate viral spread remain understudied. Furthermore, research on the effects of nonpharmaceutical interventions (NPIs) has mostly focused on national- or regional-scale implementations, leaving gaps in our understanding of the potential benefits of implementing NPIs at higher granularity. Here, we use Chile as a model to explore the role of human mobility on disease spread within the global south; the country implemented a systematic genomic surveillance program and NPIs at a very high spatial granularity. We combine viral genomic data, anonymized human mobility data from mobile phones and official records of international travelers entering the country to characterize the routes of importation of different variants, the relative contributions of airport and land border importations, and the real-time impact of the country's mobility network on the diffusion of SARS-CoV-2. The introduction of variants which are dominant in neighboring countries (and not detected through airport genomic surveillance) is predicted by land border crossings and not by air travelers, and the strength of connectivity between comunas (Chile's lowest administrative divisions) predicts the time of arrival of imported lineages to new locations. A higher stringency of local NPIs was also associated with fewer domestic viral importations. Our analysis sheds light on the drivers of emerging respiratory infectious disease spread outside of air travel and on the consequences of disrupting regular movement patterns at lower spatial scales.
Collapse
Affiliation(s)
- Bernardo Gutierrez
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
- Pandemic Sciences Institute, University of Oxford, Oxford OX3 7DQ, United Kingdom
- Colegio de Ciencias Biológicas y Ambientales, Universidad San Francisco de Quito USFQ, Quito 170901, Ecuador
| | - Joseph L -H Tsui
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
| | - Giulia Pullano
- Department of Biology, Georgetown University, Washington, DC 20057, USA
- INSERM, Sorbonne Université, Institut Pierre Louis d’Epidémiologie et de Santé Publique, IPLESP, 75012 Paris, France
| | - Mattia Mazzoli
- INSERM, Sorbonne Université, Institut Pierre Louis d’Epidémiologie et de Santé Publique, IPLESP, 75012 Paris, France
- ISI Foundation, 10126 Turin, Italy
| | - Karthik Gangavarapu
- Department of Human Genetics, University of California Los Angeles, Los Angeles, CA 90095, USA
| | - Rhys P D Inward
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
| | - Sumali Bajaj
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
| | - Rosario Evans Pena
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
| | - Simon Busch-Moreno
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
| | - Marc A Suchard
- Department of Human Genetics, University of California Los Angeles, Los Angeles, CA 90095, USA
- Department of Biostatistics, University of California Los Angeles, Los Angeles, CA 90095, USA
- Department of Biomathematics, University of California Los Angeles, Los Angeles, CA 90095, USA
| | - Oliver G Pybus
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
- Pandemic Sciences Institute, University of Oxford, Oxford OX3 7DQ, United Kingdom
- Department of Pathobiology and Population Science, Royal Veterinary College, London AL9 7TA, United Kingdom
| | | | - Rodrigo Puentes
- Instituto de Salud Pública de Chile, 7780050 Santiago, Chile
| | - Salvador Ayala
- Instituto de Salud Pública de Chile, 7780050 Santiago, Chile
| | - Jorge Fernandez
- Instituto de Salud Pública de Chile, 7780050 Santiago, Chile
| | - Rafael Araos
- Facultad de Medicina Clínica Alemana, Instituto de Ciencias e Innovación en Medicina (ICIM), Universidad del Desarrollo, 7610671 Santiago, Chile
| | - Leo Ferres
- ISI Foundation, 10126 Turin, Italy
- Data Science Institute, Universidad del Desarrollo, 7610671 Santiago, Chile
- Telefónica, 7500775 Santiago, Chile
| | - Vittoria Colizza
- INSERM, Sorbonne Université, Institut Pierre Louis d’Epidémiologie et de Santé Publique, IPLESP, 75012 Paris, France
- Tokyo Tech World Research Hub Initiative, Institute of Innovative Research, Tokyo Institute of Technology, Tokyo 152-8550, Japan
| | - Moritz U G Kraemer
- Department of Biology, University of Oxford, Oxford OX1 3SZ, United Kingdom
- Pandemic Sciences Institute, University of Oxford, Oxford OX3 7DQ, United Kingdom
| |
Collapse
|
5
|
Marques BDC, Banho CA, Sacchetto L, Negri A, Vasilakis N, Nogueira ML. Impact of Vaccination on Intra-Host Genetic Diversity of Patients Infected with SARS-CoV-2 Gamma Lineage. Viruses 2024; 16:1524. [PMID: 39459859 PMCID: PMC11512383 DOI: 10.3390/v16101524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2024] [Revised: 09/18/2024] [Accepted: 09/23/2024] [Indexed: 10/28/2024] Open
Abstract
The high transmissibility, rapid evolution, and immune escape of SARS-CoV-2 variants can influence the course of infection and, in turn, morbidity and mortality in COVID-19, posing a challenge in controlling transmission rates and contributing to the emergence and spread of new variants. Understanding the factors that shape viral genetic variation is essential for comprehending the evolution and transmission of SARS-CoV-2, especially in vaccinated individuals where immune response plays a role in the progression and spread of this disease. In this context, we evaluated the impact of immunity induced by the CoronaVac vaccine (Butantan/Sinovac) on intra-host genetic diversity, analyzing 118 whole-genome sequences of SARS-CoV-2 from unvaccinated and vaccinated patients infected with the Gamma variant. Vaccination with CoronaVac favors negative selection at the intra-host level in different genomic regions. It prevents greater genetic diversity of SARS-CoV-2, reinforcing the importance of vaccination in reducing the emergence of new mutations and virus transmission.
Collapse
Affiliation(s)
- Beatriz de Carvalho Marques
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil; (B.d.C.M.); (C.A.B.); (L.S.)
| | - Cecília Artico Banho
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil; (B.d.C.M.); (C.A.B.); (L.S.)
| | - Lívia Sacchetto
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil; (B.d.C.M.); (C.A.B.); (L.S.)
| | - Andreia Negri
- Vigilância Epidemiológica, Secretaria de Saúde de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil;
| | - Nikos Vasilakis
- Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA;
- Center for Vector-Borne and Zoonotic Diseases, University of Texas Medical Branch, Galveston, TX 77555, USA
- Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA
| | - Maurício Lacerda Nogueira
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil; (B.d.C.M.); (C.A.B.); (L.S.)
- Vigilância Epidemiológica, Secretaria de Saúde de São José do Rio Preto, São José do Rio Preto 15090-000, São Paulo, Brazil;
| |
Collapse
|
6
|
Kotov IA, Agletdinov MR, Roev GV, Pimkina EV, Nadtoka MI, Peresadina AV, Bukharina AY, Svetlichny DV, Goncharov SE, Vykhodtseva AV, Borisova NI, Lysenkov VG, Chanyshev MD, Agabalaev DNO, Saenko VV, Cherkashina AS, Semenenko TA, Dubodelov DV, Khafizov KF, Akimkin VG. Genomic surveillance of SARS-CoV-2 in Russia: insights from the VGARus platform. JOURNAL OF MICROBIOLOGY, EPIDEMIOLOGY AND IMMUNOBIOLOGY 2024; 101:435-447. [DOI: 10.36233/0372-9311-554] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/02/2025]
Abstract
Introduction. In response to the COVID-19 pandemic in the Russian Federation, comprehensive response measures were taken. One of these measures was the development of a viral genome aggregation platform (VGARus) to monitor virus variability.
The aim of this paper is to describe the role of the VGARus platform in tracking genetic variation in SARS-CoV-2.
Materials and methods. VGARus utilizes sequencing data and bioinformatics tools to monitor genetic variations in SARS-CoV-2. The viral genomes were aligned using NextClade, which also translated them into amino acids and identified mutations. The viral variability over time was analyzed by counting the number of amino acid changes compared to the reference sequence.
Results. The analysis of data within VGARus enabled the identification of new virus variants, contributing to improved diagnostic tests and vaccine development. The platform allowed for the prediction of epidemiologic trends, facilitating a rapid response to changes in the epidemiologic situation. For example, using VGARus, an increase in COVID-19 incidence was accurately predicted in the summer of 2022 and early 2023, which were associated with the emergence of Omicron subvariants BA.5 and XBB. Data from the platform helps validate the effectiveness of primers and DNA probes to ensure high diagnostic accuracy and reduce the risk of false negatives.
Conclusion. VGARus demonstrates the growing role of genomic surveillance in combating COVID-19 and improving preparedness for future infectious disease outbreaks. The platform is a powerful tool for generating evidence-based solutions to combat a pandemic and mitigate its health, economic and societal impacts. It provides the ability to promptly obtain information on the epidemiologic situation in a particular region of the Russian Federation, use genomic data for phylogenetic analysis, compare the mutational spectrum of SARS-CoV-2 sequences with foreign samples. VGARus data allow for both retrospective analysis and predictive hypotheses. For example, we can clearly see the dynamics of the change of different virus variants: sequences belonging to the Alpha, Beta, Delta, Omicron lineages and many less common ones, clearly form the upsurges of morbidity, the interaction of which is reflected in the epidemiological picture. It is also currently being expanded to monitor other pathogens, increasing its public health relevance.
Collapse
|
7
|
Fonseca PLC, Braga-Paz I, de Araújo E Santos LCG, Dias RC, de Souza CSA, Carvalho NO, Queiroz DC, Alves HJ, de Araújo JLF, Moreira FRR, Menezes MT, Menezes D, Silva ABPE, Ferreira JGG, Adelino TER, Bernardes AFL, Carobin NV, Carvalho RS, Ferrari CZ, Guimarães NR, Lamounier LO, Souza FG, Vargas LA, Ribeiro MDO, Arruda MB, Alvarez P, Moreira RG, de Oliveira ES, Sabino ADP, de Oliveira JS, Januário JN, Iani FCDM, Souza RPD, Aguiar RS. Retrospective Analysis of Omicron in Minas Gerais, Brazil: Emergence, Dissemination, and Diversification. Microorganisms 2024; 12:1745. [PMID: 39338420 PMCID: PMC11434267 DOI: 10.3390/microorganisms12091745] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2024] [Revised: 08/06/2024] [Accepted: 08/09/2024] [Indexed: 09/30/2024] Open
Abstract
Brazil is one of the countries most affected by COVID-19, with the highest number of deaths recorded. Brazilian Health Institutions have reported four main peaks of positive COVID-19 cases. The last two waves were characterized by the emergence of the VOC Omicron and its sublineages. This study aimed to conduct a retrospective surveillance study illustrating the emergence, dissemination, and diversification of the VOC Omicron in 15 regional health units (RHUs) in MG, the second most populous state in Brazil, by combining epidemiological and genomic data. A total of 5643 confirmed positive COVID-19 samples were genotyped using the panels TaqMan SARS-CoV-2 Mutation and 4Plex SC2/VOC Bio-Manguinhos to define mutations classifying the BA.1, BA.2, BA.4, and BA.5 sublineages. While sublineages BA.1 and BA.2 were more prevalent during the third wave, BA.4 and BA.5 dominated the fourth wave in the state. Epidemiological and viral genome data suggest that age and vaccination with booster doses were the main factors related to clinical outcomes, reducing the number of deaths, irrespective of the Omicron sublineages. Complete genome sequencing of 253 positive samples confirmed the circulation of the BA.1, BA.2, BA.4, and BA.5 subvariants, and phylogenomic analysis demonstrated that the VOC Omicron was introduced through multiple international events, followed by transmission within the state of MG. In addition to the four subvariants, other lineages have been identified at low frequency, including BQ.1.1 and XAG. This integrative study reinforces that the evolution of Omicron sublineages was the most significant factor driving the highest peaks of positive COVID-19 cases without an increase in more severe cases, prevented by vaccination boosters.
Collapse
Affiliation(s)
- Paula Luize Camargos Fonseca
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Isabela Braga-Paz
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Luiza Campos Guerra de Araújo E Santos
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Rillery Calixto Dias
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Carolina Senra Alves de Souza
- Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil
| | - Nara Oliveira Carvalho
- Núcleo de Ações e Pesquisa em Apoio Diagnóstico-Nupad, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Brazil
| | - Daniel Costa Queiroz
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Hugo José Alves
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - João Locke Ferreira de Araújo
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Filipe Romero Rebello Moreira
- Departamento de Genetica, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
| | - Mariane Talon Menezes
- Departamento de Genetica, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-902, Brazil
| | - Diego Menezes
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Aryel Beatriz Paz E Silva
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Jorge Gomes Goulart Ferreira
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | | | | | - Natália Virtude Carobin
- Laboratório Institucional de Pesquisa em Biomarcadores, Laboratório de Hematologia Clínica, Departamento de Análises Clínicas e Toxicológicas; Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Renée Silva Carvalho
- Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil
| | - Carolina Zaniboni Ferrari
- Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil
| | | | | | - Fernanda Gil Souza
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Luisa Aimeé Vargas
- Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil
| | - Marisa de Oliveira Ribeiro
- Institute of Technology in Immunobiology Bio-Manguinhos, Oswaldo Cruz Foundation/Fiocruz, Rio de Janeiro 21040-900, Brazil
| | - Monica Barcellos Arruda
- Institute of Technology in Immunobiology Bio-Manguinhos, Oswaldo Cruz Foundation/Fiocruz, Rio de Janeiro 21040-900, Brazil
| | - Patricia Alvarez
- Institute of Technology in Immunobiology Bio-Manguinhos, Oswaldo Cruz Foundation/Fiocruz, Rio de Janeiro 21040-900, Brazil
| | - Rennan Garcias Moreira
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | | | - Adriano de Paula Sabino
- Laboratório Institucional de Pesquisa em Biomarcadores, Laboratório de Hematologia Clínica, Departamento de Análises Clínicas e Toxicológicas; Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Jaqueline Silva de Oliveira
- Subsecretaria de Vigilância em Saúde, Secretaria de Estado de Saúde de Minas Gerais, Belo Horizonte 31585-200, Brazil
| | - José Nélio Januário
- Núcleo de Ações e Pesquisa em Apoio Diagnóstico-Nupad, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte 30130-100, Brazil
| | | | - Renan Pedra de Souza
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Renato Santana Aguiar
- Laboratório de Biologia Integrativa, Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
- Instituto D'OR de Pesquisa e Ensino, Rio de Janeiro 22281-100, Brazil
| |
Collapse
|
8
|
Banho CA, de Carvalho Marques B, Sacchetto L, Lima AKS, Parra MCP, Lima ARJ, Ribeiro G, Martins AJ, Barros CRDS, Elias MC, Sampaio SC, Slavov SN, Rodrigues ES, Santos EV, Covas DT, Kashima S, Brassaloti RA, Petry B, Clemente LG, Coutinho LL, Assato PA, da Silva da Costa FA, Grotto RMT, Poleti MD, Lesbon JCC, Mattos EC, Fukumasu H, Giovanetti M, Alcantara LCJ, Souza-Neto JA, Rahal P, Araújo JP, Spilki FR, Althouse BM, Vasilakis N, Nogueira ML. Dynamic clade transitions and the influence of vaccination on the spatiotemporal circulation of SARS-CoV-2 variants. NPJ Vaccines 2024; 9:145. [PMID: 39127725 DOI: 10.1038/s41541-024-00933-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2023] [Accepted: 07/17/2024] [Indexed: 08/12/2024] Open
Abstract
Since 2021, the emergence of variants of concern (VOC) has led Brazil to experience record numbers of in COVID-19 cases and deaths. The expanded spread of the SARS-CoV-2 combined with a low vaccination rate has contributed to the emergence of new mutations that may enhance viral fitness, leading to the persistence of the disease. Due to limitations in the real-time genomic monitoring of new variants in some Brazilian states, we aimed to investigate whether genomic surveillance, coupled with epidemiological data and SARS-CoV-2 variants spatiotemporal spread in a smaller region, can reflect the pandemic progression at a national level. Our findings revealed three SARS-CoV-2 variant replacements from 2021 to early 2022, corresponding to the introduction and increase in the frequency of Gamma, Delta, and Omicron variants, as indicated by peaks of the Effective Reproductive Number (Reff). These distinct clade replacements triggered two waves of COVID-19 cases, influenced by the increasing vaccine uptake over time. Our results indicated that the effectiveness of vaccination in preventing new cases during the Delta and Omicron circulations was six and eleven times higher, respectively, than during the period when Gamma was predominant, and it was highly efficient in reducing the number of deaths. Furthermore, we demonstrated that genomic monitoring at a local level can reflect the national trends in the spread and evolution of SARS-CoV-2.
Collapse
Affiliation(s)
- Cecília Artico Banho
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
| | - Beatriz de Carvalho Marques
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
| | - Lívia Sacchetto
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
| | - Ana Karoline Sepedro Lima
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
| | - Maisa Carla Pereira Parra
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
| | - Alex Ranieri Jeronimo Lima
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
| | - Gabriela Ribeiro
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
| | - Antonio Jorge Martins
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
| | | | - Maria Carolina Elias
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
| | - Sandra Coccuzzo Sampaio
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
| | - Svetoslav Nanev Slavov
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
- University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil
| | - Evandra Strazza Rodrigues
- University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil
| | - Elaine Vieira Santos
- University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil
| | - Dimas Tadeu Covas
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
- University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil
| | - Simone Kashima
- University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil
| | | | - Bruna Petry
- University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil
| | - Luan Gaspar Clemente
- University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil
| | - Luiz Lehmann Coutinho
- University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil
| | - Patricia Akemi Assato
- São Paulo State University (UNESP), School of Agricultural Sciences, Department of Bioprocesses and Biotechnology, Botucatu, Brazil
| | - Felipe Allan da Silva da Costa
- São Paulo State University (UNESP), School of Agricultural Sciences, Department of Bioprocesses and Biotechnology, Botucatu, Brazil
| | - Rejane Maria Tommasini Grotto
- São Paulo State University (UNESP), School of Agricultural Sciences, Botucatu, Brazil
- Molecular Biology Laboratory, Applied Biotechnology Laboratory, Clinical Hospital of the Botucatu Medical School, Botucatu, Brazil
| | - Mirele Daiana Poleti
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil
| | - Jessika Cristina Chagas Lesbon
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil
| | - Elisangela Chicaroni Mattos
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil
| | - Heidge Fukumasu
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil
| | - Marta Giovanetti
- Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, Brazil
- Climate Amplified Diseases And Epidemics (CLIMADE), Rio de Janeiro, Brazil
- Sciences and Technologies for Sustainable Development and One Health, Universita Campus Bio-Medico di Roma, Selcetta, Italy
| | - Luiz Carlos Junior Alcantara
- Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, Brazil
- Climate Amplified Diseases And Epidemics (CLIMADE), Rio de Janeiro, Brazil
| | - Jayme A Souza-Neto
- Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas StateUniversity, Manhattan, KS, USA
| | - Paula Rahal
- Laboratório de Estudos Genômicos, Departamento de Biologia, Instituto de Biociências Letras e Ciências Exatas (IBILCE), Universidade Estadual Paulista (Unesp), São José do Rio Preto, Brazil
| | - João Pessoa Araújo
- Instituto de Biotecnologia, Universidade Estadual Paulista (Unesp), Botucatu, Brazil
| | - Fernando Rosado Spilki
- Laboratório de Microbiologia Molecular, Instituto de Ciências da Saúde, Universidade Feevale, Novo Hamburgo, Brazil
| | - Benjamin M Althouse
- Department of Biology, New Mexico State University, Las Cruces, NM, USA
- Information School, University of Washington, Seattle, WA, USA
| | - Nikos Vasilakis
- Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA
- Center for Vector-Borne and Zoonotic Diseases, University of Texas Medical Branch, Galveston, TX, USA
- Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX, USA
| | - Maurício Lacerda Nogueira
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil.
- Department of Pathology, University of Texas Medical Branch, Galveston, TX, USA.
| |
Collapse
|
9
|
Oliveira JF, Alencar AL, Cunha MCLS, Vasconcelos AO, Cunha GG, Miranda RB, Filho FMHS, Silva C, Gustani-Buss E, Khouri R, Cerqueira-Silva T, Landau L, Barral-Netto M, Ramos PIP. Human mobility patterns in Brazil to inform sampling sites for early pathogen detection and routes of spread: a network modelling and validation study. Lancet Digit Health 2024; 6:e570-e579. [PMID: 39059889 DOI: 10.1016/s2589-7500(24)00099-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2024] [Revised: 05/03/2024] [Accepted: 05/10/2024] [Indexed: 07/28/2024]
Abstract
BACKGROUND Detecting and foreseeing pathogen dispersion is crucial in preventing widespread disease transmission. Human mobility is a fundamental issue in human transmission of infectious agents. Through a mobility data-driven approach, we aimed to identify municipalities in Brazil that could comprise an advanced sentinel network, allowing for early detection of circulating pathogens and their associated transmission routes. METHODS In this modelling and validation study, we compiled a comprehensive dataset on intercity mobility spanning air, road, and waterway transport from the Brazilian Institute of Geography and Statistics (2016 data), National Transport Confederation (2022), and National Civil Aviation Agency (2017-23). We constructed a graph-based representation of Brazil's mobility network. The Ford-Fulkerson algorithm was used to rank the 5570 Brazilian cities according to their suitability as sentinel locations, allowing us to predict the most suitable locations for early detection and to track the most likely trajectory of a newly emerged pathogen. We also obtained SARS-CoV-2 genetic data from Brazilian municipalities during the early stage (Feb 25-April 30, 2020) of the virus's introduction and the gamma (P.1) variant emergence in Manaus (Jan 6-March 1, 2021), for the purposes of model validation. FINDINGS We found that flights alone transported 79·9 million (95% CI 58·3-101·4 million) passengers annually within Brazil during 2017-22, with seasonal peaks occurring in late spring and summer, and road and river networks had a maximum capacity of 78·3 million passengers weekly in 2016. By analysing the 7 746 479 most probable paths originating from source nodes, we found that 3857 cities fully cover the mobility pattern of all 5570 cities in Brazil, 557 (10·0%) of which cover 6 313 380 (81·5%) of the mobility patterns in our study. By strategically incorporating mobility patterns into Brazil's existing influenza-like illness surveillance network (ie, by switching the location of 111 of 199 sentinel sites to different municipalities), our model predicted that mobility coverage would have a 33·6% improvement from 4 059 155 (52·4%) mobility patterns to 5 422 535 (70·0%) without expanding the number of sentinel sites. Our findings are validated with genomic data collected during the SARS-CoV-2 pandemic period. Our model accurately mapped 22 (51%) of 43 clade 1-affected cities and 28 (60%) of 47 clade 2-affected cities spread from São Paulo city, and 20 (49%) of 41 clade 1-affected cities and 28 (58%) of 48 clade 2-affected cities spread from Rio de Janeiro city, Feb 25-April 30, 2020. Additionally, 224 (73%) of the 307 suggested early-detection locations for pathogens emerging in Manaus corresponded with the first cities affected by the transmission of the gamma variant, Jan 6-16, 2021. INTERPRETATION By providing essential clues for effective pathogen surveillance, our results have the potential to inform public health policy and improve future pandemic response efforts. Our results unlock the potential of designing country-wide clinical sample collection networks with mobility data-informed approaches, an innovative practice that can improve current surveillance systems. FUNDING Rockefeller Foundation.
Collapse
Affiliation(s)
- Juliane F Oliveira
- Center for Data and Knowledge Integration for Health (CIDACS), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz), Salvador, Brazil; Centre of Mathematics of the University of Porto (CMUP), Department of Mathematics, University of Porto, Porto, Portugal.
| | - Andrêza L Alencar
- Department of Computer Science, Federal Rural University of Pernambuco, Recife, Brazil
| | - Maria Célia L S Cunha
- Luiz Coimbra Institute of Graduate and Engineering Research (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - Adriano O Vasconcelos
- Luiz Coimbra Institute of Graduate and Engineering Research (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - Gerson G Cunha
- Luiz Coimbra Institute of Graduate and Engineering Research (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - Ray B Miranda
- Luiz Coimbra Institute of Graduate and Engineering Research (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - Fábio M H S Filho
- Rondônia Oswaldo Cruz Foundation, Oswaldo Cruz Foundation (Fiocruz), Porto Velho, Brazil
| | - Corbiniano Silva
- Luiz Coimbra Institute of Graduate and Engineering Research (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - Emanuele Gustani-Buss
- Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven-University of Leuven, Leuven, Belgium
| | - Ricardo Khouri
- Medicine and Precision Public Health Laboratory (MeSP2), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz), Salvador, Brazil
| | - Thiago Cerqueira-Silva
- Center for Data and Knowledge Integration for Health (CIDACS), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz), Salvador, Brazil
| | - Luiz Landau
- Luiz Coimbra Institute of Graduate and Engineering Research (COPPE), Federal University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil
| | - Manoel Barral-Netto
- Center for Data and Knowledge Integration for Health (CIDACS), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz), Salvador, Brazil; Medicine and Precision Public Health Laboratory (MeSP2), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz), Salvador, Brazil
| | - Pablo Ivan P Ramos
- Center for Data and Knowledge Integration for Health (CIDACS), Gonçalo Moniz Institute, Oswaldo Cruz Foundation (Fiocruz), Salvador, Brazil
| |
Collapse
|
10
|
Ferreira da Silva L, Alcantara LCJ, Fonseca V, Frias D, Umaki Zardin MCS, de Castro Lichs GG, Esposito AOP, Xavier J, Fritsch H, Lima M, de Oliveira C, Castilho de Arruda LD, Maziero LDMA, Rodrigues Barretos EC, Tsuha Oshiro PE, Gimenes Mendes Menezes EF, de Freitas Cardoso L, Ferreira Lemos E, Lourenço J, de Albuquerque CFC, do Carmo Said RF, Rosewell A, Ferraz Demarchi LH, Croda J, Giovanetti M, Maymone Gonçalves CC. Insights into SARS-CoV-2 Surveillance among Prison Populations in Mato Grosso do Sul, Brazil, in 2022. Viruses 2024; 16:1143. [PMID: 39066305 PMCID: PMC11281713 DOI: 10.3390/v16071143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2024] [Revised: 07/09/2024] [Accepted: 07/15/2024] [Indexed: 07/28/2024] Open
Abstract
This study examines the epidemiological and genomic characteristics, along with the transmission dynamics, of SARS-CoV-2 within prison units I and II in Campo Grande, Mato Grosso do Sul, Brazil. Conducted between May and October 2022, it reveals how the virus spreads in the confined settings of prisons, emphasizing the roles of overcrowded cells, frequent transfers, and limited healthcare access. The research involved 1927 participants (83.93% of the total prison population) and utilized nasopharyngeal swabs and RT-qPCR testing for detection. Contact tracing monitored exposure within cells. Out of 2108 samples, 66 positive cases were identified (3.13%), mostly asymptomatic (77.27%), with the majority aged 21-29 and varying vaccination statuses. Next-generation sequencing generated 28 whole genome sequences, identifying the Omicron variant (subtypes BA.2 and BA.5) with 99% average coverage. Additionally, the study seeks to determine the relationship between immunization levels and the incidence of SARS-CoV-2 cases within this enclosed population. The findings underscore the necessity of comprehensive control strategies in prisons, including rigorous screening, isolation protocols, vaccination, epidemiological monitoring, and genomic surveillance to mitigate disease transmission and protect both the incarcerated population and the broader community.
Collapse
Affiliation(s)
- Liliane Ferreira da Silva
- Secretaria de Estado de Saúde, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (L.F.d.S.); (L.D.C.d.A.); (L.d.M.A.M.); (E.C.R.B.); (P.E.T.O.); (E.F.G.M.M.); (L.d.F.C.); (C.C.M.G.)
- School of Medicine, Universidade Federal de Mato Grosso do Sul, Campo Grande 79070-900, Mato Grosso do Sul, Brazil
| | - Luiz Carlos Junior Alcantara
- Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Minas Gerais, Brazil; (L.C.J.A.); (J.X.); (H.F.); (M.L.)
- Climate Amplified Diseases and Epidemics (CLIMADE), Bairro Floresta 31110-370, Minas Gerais, Brazil
| | - Vagner Fonseca
- Climate Amplified Diseases and Epidemics (CLIMADE), Bairro Floresta 31110-370, Minas Gerais, Brazil
- Departamento de Ciências Exatas e da Terra, Universidade do Estado da Bahia, Salvador 40301-110, Bahia, Brazil;
- Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch 7600, South Africa
| | - Diego Frias
- Departamento de Ciências Exatas e da Terra, Universidade do Estado da Bahia, Salvador 40301-110, Bahia, Brazil;
| | - Marina Castilhos Souza Umaki Zardin
- Laboratório Central de Saúde Pública de Mato Grosso do Sul/SES/MS, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (A.O.P.E.); (L.H.F.D.)
| | - Gislene Garcia de Castro Lichs
- Laboratório Central de Saúde Pública de Mato Grosso do Sul/SES/MS, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (A.O.P.E.); (L.H.F.D.)
| | - Ana Olivia Pascoto Esposito
- Laboratório Central de Saúde Pública de Mato Grosso do Sul/SES/MS, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (A.O.P.E.); (L.H.F.D.)
| | - Joilson Xavier
- Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Minas Gerais, Brazil; (L.C.J.A.); (J.X.); (H.F.); (M.L.)
| | - Hegger Fritsch
- Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Minas Gerais, Brazil; (L.C.J.A.); (J.X.); (H.F.); (M.L.)
| | - Mauricio Lima
- Instituto René Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Minas Gerais, Brazil; (L.C.J.A.); (J.X.); (H.F.); (M.L.)
| | - Carla de Oliveira
- Laboratório de Arbovírus e Vírus Hemorrágicos, Instituto Oswaldo Cruz, Manguinhos 21040-900, Rio de Janeiro, Brazil;
| | - Larissa Domingues Castilho de Arruda
- Secretaria de Estado de Saúde, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (L.F.d.S.); (L.D.C.d.A.); (L.d.M.A.M.); (E.C.R.B.); (P.E.T.O.); (E.F.G.M.M.); (L.d.F.C.); (C.C.M.G.)
- School of Medicine, Universidade Federal de Mato Grosso do Sul, Campo Grande 79070-900, Mato Grosso do Sul, Brazil
| | - Livia de Mello Almeida Maziero
- Secretaria de Estado de Saúde, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (L.F.d.S.); (L.D.C.d.A.); (L.d.M.A.M.); (E.C.R.B.); (P.E.T.O.); (E.F.G.M.M.); (L.d.F.C.); (C.C.M.G.)
- School of Medicine, Universidade Federal de Mato Grosso do Sul, Campo Grande 79070-900, Mato Grosso do Sul, Brazil
| | - Ellen Caroline Rodrigues Barretos
- Secretaria de Estado de Saúde, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (L.F.d.S.); (L.D.C.d.A.); (L.d.M.A.M.); (E.C.R.B.); (P.E.T.O.); (E.F.G.M.M.); (L.d.F.C.); (C.C.M.G.)
| | - Paulo Eduardo Tsuha Oshiro
- Secretaria de Estado de Saúde, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (L.F.d.S.); (L.D.C.d.A.); (L.d.M.A.M.); (E.C.R.B.); (P.E.T.O.); (E.F.G.M.M.); (L.d.F.C.); (C.C.M.G.)
| | - Evellyn Fernanda Gimenes Mendes Menezes
- Secretaria de Estado de Saúde, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (L.F.d.S.); (L.D.C.d.A.); (L.d.M.A.M.); (E.C.R.B.); (P.E.T.O.); (E.F.G.M.M.); (L.d.F.C.); (C.C.M.G.)
| | - Lucélia de Freitas Cardoso
- Secretaria de Estado de Saúde, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (L.F.d.S.); (L.D.C.d.A.); (L.d.M.A.M.); (E.C.R.B.); (P.E.T.O.); (E.F.G.M.M.); (L.d.F.C.); (C.C.M.G.)
| | - Everton Ferreira Lemos
- School of Medicine, Universidade Estadual do Mato Grosso do Sul, Campo Grande 79070-900, Mato Grosso do Sul, Brazil;
| | - José Lourenço
- Faculdade de Medicina, Universidade Católica Portuguesa, Biomedical Research Center, 1649-023 Lisbon, Portugal
- Climate Amplified Diseases and Epidemics (CLIMADE), 1749-016 Lisbon, Portugal
| | - Carlos F. C. de Albuquerque
- Coordenação de Vigilância, Preparação e Resposta à Emergências e Desastres (PHE), Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasília 25045-002, Federal District, Brazil; (C.F.C.d.A.); (R.F.d.C.S.); (A.R.)
| | - Rodrigo Fabiano do Carmo Said
- Coordenação de Vigilância, Preparação e Resposta à Emergências e Desastres (PHE), Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasília 25045-002, Federal District, Brazil; (C.F.C.d.A.); (R.F.d.C.S.); (A.R.)
| | - Alexander Rosewell
- Coordenação de Vigilância, Preparação e Resposta à Emergências e Desastres (PHE), Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasília 25045-002, Federal District, Brazil; (C.F.C.d.A.); (R.F.d.C.S.); (A.R.)
| | - Luiz Henrique Ferraz Demarchi
- Laboratório Central de Saúde Pública de Mato Grosso do Sul/SES/MS, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (A.O.P.E.); (L.H.F.D.)
| | - Julio Croda
- Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande 79070-900, Mato Grosso do Sul, Brazil;
- Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, CT 06510, USA
- Fundação Oswaldo Cruz, Mato Grosso do Sul, Universidade Federal de Mato Grosso do Sul, Campo Grande 79070-900, Mato Grosso do Sul, Brazil
| | - Marta Giovanetti
- Department of Sciences and Technologies for Sustainable Development and One Health, Universita Campus Bio-Medico di Roma, 00128 Selcetta, Italy
- Oswaldo Cruz Foundation, Manguinhos 21040-900, Rio de Janeiro, Brazil
| | - Crhistinne Cavalheiro Maymone Gonçalves
- Secretaria de Estado de Saúde, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (L.F.d.S.); (L.D.C.d.A.); (L.d.M.A.M.); (E.C.R.B.); (P.E.T.O.); (E.F.G.M.M.); (L.d.F.C.); (C.C.M.G.)
- School of Medicine, Universidade Federal de Mato Grosso do Sul, Campo Grande 79070-900, Mato Grosso do Sul, Brazil
- Laboratório Central de Saúde Pública de Mato Grosso do Sul/SES/MS, Campo Grande 79031-350, Mato Grosso do Sul, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (A.O.P.E.); (L.H.F.D.)
- Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande 79070-900, Mato Grosso do Sul, Brazil;
| |
Collapse
|
11
|
Alemán GV, Cerpas C, Juarez JG, Moreira H, Arguello S, Coloma J, Harris E, Gordon A, Bennett SN, Balmaseda Á. Tracking the genetic diversity of SARS-CoV-2 variants in Nicaragua throughout the COVID-19 Pandemic. BIORXIV : THE PREPRINT SERVER FOR BIOLOGY 2024:2024.06.03.596876. [PMID: 38895444 PMCID: PMC11185506 DOI: 10.1101/2024.06.03.596876] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/21/2024]
Abstract
The global circulation of SARS-CoV-2 has been extensively documented, yet the dynamics within Central America, particularly Nicaragua, remain underexplored. This study characterizes the genomic diversity of SARS-CoV-2 in Nicaragua from March 2020 through December 2022, utilizing 1064 genomes obtained via next-generation sequencing. These sequences were selected nationwide and analyzed for variant classification, lineage predominance, and phylogenetic diversity. We employed both Illumina and Oxford Nanopore Technologies for all sequencing procedures. Results indicated a temporal and spatial shift in dominant lineages, initially from B.1 and A.2 in early 2020 to various Omicron subvariants towards the study's end. Significant lineage shifts correlated with changes in COVID-19 positivity rates, underscoring the epidemiological impact of variant dissemination. The comparative analysis with regional data underscored the low diversity of circulating lineages in Nicaragua and their delayed introduction compared to other countries in the Central American region. The study also linked specific viral mutations with hospitalization rates, emphasizing the clinical relevance of genomic surveillance. This research advances the understanding of SARS-CoV-2 evolution in Nicaragua and provide valuable information regarding its genetic diversity for public health officials in Central America. We highlight the critical role of ongoing genomic surveillance in identifying emergent lineages and informing public health strategies.
Collapse
Affiliation(s)
| | - Cristhiam Cerpas
- Sustainable Sciences Institute, Managua, Nicaragua
- Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia Ministerio de Salud, Managua, Nicaragua
| | | | | | | | - Josefina Coloma
- Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
| | - Eva Harris
- Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA
| | | | | | - Ángel Balmaseda
- Sustainable Sciences Institute, Managua, Nicaragua
- Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia Ministerio de Salud, Managua, Nicaragua
| |
Collapse
|
12
|
Machado LC, Dezordi FZ, de Lima GB, de Lima RE, Silva LCA, Pereira LDM, da Silva AF, da Silva Neto AM, de Oliveira ALS, Armstrong ADC, Pessoa-e-Silva R, Loyo RM, Silva BDO, de Almeida AR, da Rocha Pitta MG, Santos FDADS, Mendonça Siqueira M, Resende PC, Delatorre E, Naveca FG, Miyajima F, Gräf T, do Carmo RF, Pereira MC, Campos TDL, Bezerra MF, Paiva MHS, Wallau GDL. Spatiotemporal transmission of SARS-CoV-2 lineages during 2020-2021 in Pernambuco-Brazil. Microbiol Spectr 2024; 12:e0421823. [PMID: 38651879 PMCID: PMC11237429 DOI: 10.1128/spectrum.04218-23] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2023] [Accepted: 04/04/2024] [Indexed: 04/25/2024] Open
Abstract
SARS-CoV-2 virus emerged as a new threat to humans and spread around the world, leaving a large death toll. As of January 2023, Brazil is among the countries with the highest number of registered deaths. Nonpharmacological and pharmacological interventions have been heterogeneously implemented in the country, which, associated with large socioeconomic differences between the country regions, has led to distinct virus spread dynamics. Here, we investigate the spatiotemporal dispersion of SARS-CoV-2 lineages in the Pernambuco state (Northeast Brazil) throughout the distinct epidemiological scenarios that unfolded in the first 2 years of the pandemic. We generated a total of 1,389 new SARS-CoV-2 genomes from June 2020 to August 2021. This sampling captured the arrival, communitary transmission, and the circulation of the B1.1, B.1.1.28, and B.1.1.33 lineages; the emergence of the former variant of interest P.2; and the emergence and fast replacement of all previous variants by the more transmissible variant of concern P.1 (Gamma). Based on the incidence and lineage spread pattern, we observed an East-to-West to inner state pattern of transmission, which is in agreement with the transmission of more populous metropolitan areas to medium- and small-size country-side cities in the state. Such transmission patterns may be partially explained by the main routes of traffic across municipalities in the state. Our results highlight that the fine-grained intrastate analysis of lineages and incidence spread can provide actionable insights for planning future nonpharmacological intervention for air-borne transmissible human pathogens.IMPORTANCEDuring the COVID-19 pandemic, Brazil was one of the most affected countries, mainly due its continental-size, socioeconomic differences among regions, and heterogeneous implementation of intervention methods. In order to investigate SARS-CoV-2 dynamics in the state of Pernambuco, we conducted a spatiotemporal dispersion study, covering the period from June 2020 to August 2021, to comprehend the dynamics of viral transmission during the first 2 years of the pandemic. Throughout this study, we were able to track three significant epidemiological waves of transmission caused by B1.1, B.1.1.28, B.1.1.33, P.2, and P.1 lineages. These analyses provided valuable insights into the evolution of the epidemiological landscape, contributing to a deeper understanding of the dynamics of virus transmission during the early years of the pandemic in the state of Pernambuco.
Collapse
Affiliation(s)
- Lais Ceschini Machado
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife, Pernambuco, Brazil
| | - Filipe Zimmer Dezordi
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife, Pernambuco, Brazil
- Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
| | - Gustavo Barbosa de Lima
- Núcleo de Plataformas Tecnológicas (NPT), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
| | - Raul Emídio de Lima
- Núcleo de Plataformas Tecnológicas (NPT), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
| | - Lilian Caroliny Amorim Silva
- Núcleo de Plataformas Tecnológicas (NPT), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
| | - Leandro de Mattos Pereira
- Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
| | - Alexandre Freitas da Silva
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife, Pernambuco, Brazil
- Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
| | | | - André Luiz Sá de Oliveira
- Núcleo de Estatística e Geoprocessamento, Instituto Aggeu Magalhães (IAM)- Fundação Oswaldo Cruz Pernambuco- FIOCRUZ-PE, Recife, Brazil
| | | | - Rômulo Pessoa-e-Silva
- Suely-Galdino Therapeutic Innovation Research Center (NUPIT-SG), Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
| | - Rodrigo Moraes Loyo
- Departamento de Parasitologia, Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
| | - Barbara de Oliveira Silva
- Suely-Galdino Therapeutic Innovation Research Center (NUPIT-SG), Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
| | - Anderson Rodrigues de Almeida
- Suely-Galdino Therapeutic Innovation Research Center (NUPIT-SG), Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
| | - Maira Galdino da Rocha Pitta
- Suely-Galdino Therapeutic Innovation Research Center (NUPIT-SG), Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
| | | | - Marilda Mendonça Siqueira
- Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil
| | - Paola Cristina Resende
- Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil
| | - Edson Delatorre
- Departamento de Biologia, Centro de Ciências Exatas, Naturais e da Saúde, Universidade Federal do Espírito Santo, Alegre, Espírito Santo, Brazil
| | - Felipe Gomes Naveca
- Laboratório de Ecologia de Doenças Transmissíveis na Amazônia (EDTA), Instituto Leônidas e Maria Deane, FIOCRUZ-Amazonas, Manaus, Amazonas, Brazil
| | - Fabio Miyajima
- Analytical Competence Molecular Epidemiology Laboratory (ACME), FIOCRUZ-Ceará, Fortaleza, Ceará, Brazil
| | - Tiago Gräf
- Laboratório de Virologia Molecular, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba, Paraná, Brazil
| | | | - Michelly Cristiny Pereira
- Suely-Galdino Therapeutic Innovation Research Center (NUPIT-SG), Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
| | - Tulio de Lima Campos
- Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
| | - Matheus Filgueira Bezerra
- Departamento de Microbiologia, Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
| | - Marcelo Henrique Santos Paiva
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife, Pernambuco, Brazil
- Núcleo de Ciências da Vida, Universidade Federal de Pernambuco (UFPE), Centro Acadêmico do Agreste, Caruaru, Brazil
| | - Gabriel da Luz Wallau
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife, Pernambuco, Brazil
- Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
- Department of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, WHO Collaborating Center for Arbovirus and Hemorrhagic Fever Reference and Research, National Reference Center for Tropical Infectious Diseases, Hamburg, Germany
| | - On behalf of Fiocruz COVID-19 Genomic Network
- Departamento de Entomologia, Instituto Aggeu Magalhães (IAM)-Fundação Oswaldo Cruz-FIOCRUZ, Recife, Pernambuco, Brazil
- Núcleo de Bioinformática (NBI), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
- Núcleo de Plataformas Tecnológicas (NPT), Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
- Núcleo de Estatística e Geoprocessamento, Instituto Aggeu Magalhães (IAM)- Fundação Oswaldo Cruz Pernambuco- FIOCRUZ-PE, Recife, Brazil
- Colegiado de Medicina, Universidade Federal do Vale do São Francisco, Petrolina, Brazil
- Suely-Galdino Therapeutic Innovation Research Center (NUPIT-SG), Federal University of Pernambuco (UFPE), Recife, Pernambuco, Brazil
- Departamento de Parasitologia, Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
- Núcleo de Ciências da Vida, Universidade Federal de Pernambuco (UFPE), Centro Acadêmico do Agreste, Caruaru, Brazil
- Laboratory of Respiratory Viruses and Measles (LVRS), Instituto Oswaldo Cruz, FIOCRUZ-Rio de Janeiro, Rio de Janeiro, Brazil
- Departamento de Biologia, Centro de Ciências Exatas, Naturais e da Saúde, Universidade Federal do Espírito Santo, Alegre, Espírito Santo, Brazil
- Laboratório de Ecologia de Doenças Transmissíveis na Amazônia (EDTA), Instituto Leônidas e Maria Deane, FIOCRUZ-Amazonas, Manaus, Amazonas, Brazil
- Analytical Competence Molecular Epidemiology Laboratory (ACME), FIOCRUZ-Ceará, Fortaleza, Ceará, Brazil
- Laboratório de Virologia Molecular, Instituto Carlos Chagas, Fundação Oswaldo Cruz, Curitiba, Paraná, Brazil
- Colegiado de Ciências Farmacêuticas, Universidade Federal do Vale do São Francisco, Petrolina, Brazil
- Departamento de Microbiologia, Instituto Aggeu Magalhães (IAM), FIOCRUZ-Pernambuco, Recife, Pernambuco, Brazil
- Department of Arbovirology, Bernhard Nocht Institute for Tropical Medicine, WHO Collaborating Center for Arbovirus and Hemorrhagic Fever Reference and Research, National Reference Center for Tropical Infectious Diseases, Hamburg, Germany
| |
Collapse
|
13
|
Reis AS, dos Santos L, Cunha Jr A, Konstantyner TC, Macau EE. Unravelling COVID-19 waves in Rio de Janeiro city: Qualitative insights from nonlinear dynamic analysis. Infect Dis Model 2024; 9:314-328. [PMID: 38371873 PMCID: PMC10867657 DOI: 10.1016/j.idm.2024.01.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2023] [Revised: 11/23/2023] [Accepted: 01/21/2024] [Indexed: 02/20/2024] Open
Abstract
Since the COVID-19 pandemic was first reported in 2019, it has rapidly spread around the world. Many countries implemented several measures to try to control the virus spreading. The healthcare system and consequently the general quality of life population in the cities have all been significantly impacted by the Coronavirus pandemic. The different waves of contagious were responsible for the increase in the number of cases that, unfortunately, many times lead to death. In this paper, we aim to characterize the dynamics of the six waves of cases and deaths caused by COVID-19 in Rio de Janeiro city using techniques such as the Poincaré plot, approximate entropy, second-order difference plot, and central tendency measures. Our results reveal that by examining the structure and patterns of the time series, using a set of non-linear techniques we can gain a better understanding of the role of multiple waves of COVID-19, also, we can identify underlying dynamics of disease spreading and extract meaningful information about the dynamical behavior of epidemiological time series. Such findings can help to closely approximate the dynamics of virus spread and obtain a correlation between the different stages of the disease, allowing us to identify and categorize the stages due to different virus variants that are reflected in the time series.
Collapse
Affiliation(s)
- Adriane S. Reis
- Institute of Science and Technology, Federal University of São Paulo, São José dos Campos, SP, Brazil
- Physics Institute, University of São Paulo, São Paulo, SP, Brazil
| | - Laurita dos Santos
- Scientific and Technological Institute, Universidade Brasil, São Paulo, SP, Brazil
| | - Américo Cunha Jr
- Department of Applied Mathematics, Rio de Janeiro State University, Rio de Janeiro, RJ, Brazil
| | | | - Elbert E.N. Macau
- Institute of Science and Technology, Federal University of São Paulo, São José dos Campos, SP, Brazil
| |
Collapse
|
14
|
Teixeira DG, Rodrigues-Neto JF, da Cunha DCS, Jeronimo SMB. Understanding SARS-CoV-2 spike glycoprotein clusters and their impact on immunity of the population from Rio Grande do Norte, Brazil. INFECTION, GENETICS AND EVOLUTION : JOURNAL OF MOLECULAR EPIDEMIOLOGY AND EVOLUTIONARY GENETICS IN INFECTIOUS DISEASES 2024; 118:105556. [PMID: 38242186 DOI: 10.1016/j.meegid.2024.105556] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/15/2023] [Revised: 01/09/2024] [Accepted: 01/15/2024] [Indexed: 01/21/2024]
Abstract
SARS-CoV-2 genome underwent mutations since it started circulating within the human population. The aim of this study was to understand the fluctuation of the spike clusters concomitant to the population immunity either due to natural infection and/or vaccination in a state of Brazil that had both high rate of natural infection and vaccination coverage. A total of 1725 SARS-CoV-2 sequences from the state of Rio Grande do Norte, Brazil, were retrieved from GISAID and subjected to cluster analysis. Immunoinformatics were used to predict T- and B-cell epitopes, followed by simulation to estimate either pro- or anti-inflammatory responses and to correlate with circulating variants. From March 2020 to June 2022, the state of Rio Grande do Norte reported 579,931 COVID-19 cases with a 1.4% fatality rate across the three major waves: May-Sept 2020, Feb-Aug 2021, and Jan-Mar 2022. Cluster 0 variants (wild type strain, Zeta) were prevalent in the first wave and Delta (AY.*), which circulated in Brazil in the latter half of 2021, featuring fewer unique epitopes. Cluster 1 (Gamma (P.1 + P.1.*)) dominated the first half of 2021. Late 2021 had two new clusters, Cluster 2 (Omicron, (B.1.1.529 + BA.*)), and Cluster 3 (BA.*) with the most unique epitopes, in addition to Cluster 4 (Delta sub lineages) which emerged in the second half of 2021 with fewer unique epitopes. Cluster 1 epitopes showed a high pro-inflammatory propensity, while others exhibited a balanced cytokine induction. The clustering method effectively identified Spike groups that may contribute to immune evasion and clinical presentation, and explain in part the clinical outcome.
Collapse
Affiliation(s)
- Diego Gomes Teixeira
- Instituto de Medicina Tropical do Rio Grande do Norte, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - João Firmino Rodrigues-Neto
- Instituto de Medicina Tropical do Rio Grande do Norte, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil; Escola Multicampi de Ciências Médicas do Rio Grande do Norte, Universidade Federal do Rio Grande do Norte, Caicó, Rio Grande do Norte, Brazil
| | - Dayse Caroline Severiano da Cunha
- Instituto de Medicina Tropical do Rio Grande do Norte, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil
| | - Selma Maria Bezerra Jeronimo
- Instituto de Medicina Tropical do Rio Grande do Norte, Universidade Federal do Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil; Departmento de Bioquímica, Centro de Biociências, Universidade Federal do Rio Grande Norte, Natal, Rio Grande do Norte, Brazil; Instituto Nacional de Ciência e Tecnologia de Doenças Tropicais, Natal, Rio Grande do Norte, Brazil.
| |
Collapse
|
15
|
Giovanetti M, Pannella G, Altomare A, Rocchi G, Guarino M, Ciccozzi M, Riva E, Gherardi G. Exploring the Interplay between COVID-19 and Gut Health: The Potential Role of Prebiotics and Probiotics in Immune Support. Viruses 2024; 16:370. [PMID: 38543736 PMCID: PMC10975078 DOI: 10.3390/v16030370] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2024] [Revised: 02/23/2024] [Accepted: 02/26/2024] [Indexed: 05/23/2024] Open
Abstract
The COVID-19 pandemic has profoundly impacted global health, leading to extensive research focused on developing strategies to enhance outbreak response and mitigate the disease's severity. In the aftermath of the pandemic, attention has shifted towards understanding and addressing long-term health implications, particularly in individuals experiencing persistent symptoms, known as long COVID. Research into potential interventions to alleviate long COVID symptoms has intensified, with a focus on strategies to support immune function and mitigate inflammation. One area of interest is the gut microbiota, which plays a crucial role in regulating immune responses and maintaining overall health. Prebiotics and probiotics, known for their ability to modulate the gut microbiota, have emerged as potential therapeutic agents in bolstering immune function and reducing inflammation. This review delves into the intricate relationship between long COVID, the gut microbiota, and immune function, with a specific focus on the role of prebiotics and probiotics. We examine the immune response to long COVID, emphasizing the importance of inflammation and immune regulation in the persistence of symptoms. The potential of probiotics in modulating immune responses, including their mechanisms in combating viral infections such as COVID-19, is discussed in detail. Clinical evidence supporting the use of probiotics in managing long COVID symptoms is summarized, highlighting their role as adjunctive therapy in addressing various aspects of SARS-CoV-2 infection and its aftermath.
Collapse
Affiliation(s)
- Marta Giovanetti
- Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, 00128 Roma, Italy; (G.P.); (A.A.)
- Climate Amplified Diseases and Epidemics (CLIMADE), Brasilia 70070-130, Brazil
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Brazil
| | - Gianfranco Pannella
- Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, 00128 Roma, Italy; (G.P.); (A.A.)
- Department of Agricultural, Enviromental and Food Science, University of Molise, 86100 Campobasso, Italy
| | - Annamaria Altomare
- Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, 00128 Roma, Italy; (G.P.); (A.A.)
- Research Unit of Gastroenterology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy; (G.R.); (M.G.)
| | - Giulia Rocchi
- Research Unit of Gastroenterology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy; (G.R.); (M.G.)
| | - Michele Guarino
- Research Unit of Gastroenterology, Università Campus Bio-Medico di Roma, 00128 Rome, Italy; (G.R.); (M.G.)
- Operative Research Unit of Gastroenterology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy
| | - Massimo Ciccozzi
- Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, 00128 Roma, Italy;
| | - Elisabetta Riva
- Unit of Virology, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy;
- Applied Bacteriological Sciences Unit, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, 00128 Rome, Italy
| | - Giovanni Gherardi
- Applied Bacteriological Sciences Unit, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, 00128 Rome, Italy
| |
Collapse
|
16
|
Stirland I, Soares MR, Furtado CLM, Dos Reis RM, Aston KI, Smith RP, Jenkins TG. An assessment of alterations to human sperm methylation patterns in coronavirus disease 2019 infected and healthy control males. F&S SCIENCE 2024; 5:2-15. [PMID: 38070681 DOI: 10.1016/j.xfss.2023.12.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/31/2023] [Revised: 12/05/2023] [Accepted: 12/05/2023] [Indexed: 01/06/2024]
Abstract
OBJECTIVE To determine whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection affects male reproductive health, considering the many potential factors that contribute to declines in male fertility on a semiglobal scale. DESIGN In total, 64 human semen samples-32 treatment and 32 control-were laboratory processed and bioinformatically analyzed to assess differences in DNA methylation patterns. Implementing multiple bioinformatic tools, the analyses conducted will elicit between-group differences with respect to epigenetic age, epigenetic instability, semiglobal, and regional methylation, in addition to methylation patterns as a function of time since infection. SETTING University hospital. PATIENTS The study cohort of 64 individuals was drawn from a larger population of 94 volunteer participants recruited at the Human Reproduction Center at the Clinical Hospital of the Ribeirao Preto Medical School-University of São Paulo between June 2021 and January 2022 as well as in accordance with the ethical guidelines established by the Declaration of Helsinki. INTERVENTION Exposure to SARS-CoV-2. MAIN OUTCOME MEASURE(S) Effects on male reproductive health were reported as differences in DNA methylation measured using an array. Mean β values at key regulatory loci for human spermatocytes were analyzed and compared between groups. Further analysis of β values using epigenetic age, instability, semiglobal, and regional methylation tools provided an analysis with substantial breadth and depth. RESULTS In all analyses, there were no differences between groups. Considering these results, it can be inferred that infection with SARS-CoV-2 does not alter the epigenome of human spermatocytes in significant and/or persistent ways. Tangentially, these data also suggest that human male reproductive health is minimally altered by the virus, or that it is altered in a way that is independent of epigenetic programming. CONCLUSION Infection with SARS-CoV-2 has been reportedly associated with alterations in male fertility. This study asserts that such alterations do not have an epigenetic basis but are likely a result of concomitant symptomatology, i.e., fever and inflammation. Across the multiple bioinformatic analyses conducted, the results of this test did not detect any differences in DNA methylation patterns between coronavirus disease 2019 and noncoronavirus disease semen donor groups.
Collapse
Affiliation(s)
- Isaac Stirland
- Department of Cell Biology and Physiology, Brigham Young University, Provo, Utah
| | - Murilo Racy Soares
- Department of Obstetrics and Gynecology, Ribeirao Preto Medical School University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
| | - Cristiana Libardi Miranda Furtado
- Department of Obstetrics and Gynecology, Ribeirao Preto Medical School University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil; University of Fortaleza, Experimental Biology Center, Fortaleza, Ceara, Brazil
| | - Rosana Maria Dos Reis
- Department of Obstetrics and Gynecology, Ribeirao Preto Medical School University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
| | - Kenneth I Aston
- Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah
| | - R Parker Smith
- Department of Cell Biology and Physiology, Brigham Young University, Provo, Utah
| | - Timothy G Jenkins
- Department of Cell Biology and Physiology, Brigham Young University, Provo, Utah; Department of Surgery, University of Utah School of Medicine, Salt Lake City, Utah.
| |
Collapse
|
17
|
Titze-de-Almeida R, Araújo Lacerda PH, de Oliveira EP, de Oliveira MEF, Vianna YSS, Costa AM, Pereira Dos Santos E, Guérard LMC, Ferreira MADM, Rodrigues Dos Santos IC, Gonçalves JDDS, Ginani Ferreira G, Souza Titze-de-Almeida S, Brandão PRDP, Eri Shimizu H, Silva APB, Delgado-Rodrigues RN. Sleep and memory complaints in long COVID: an insight into clustered psychological phenotypes. PeerJ 2024; 12:e16669. [PMID: 38313024 PMCID: PMC10836207 DOI: 10.7717/peerj.16669] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/08/2023] [Accepted: 11/22/2023] [Indexed: 02/06/2024] Open
Abstract
This study evaluated clinical features of individuals with long COVID (5-8 months after diagnosis) who reported sleep and memory problems (62 cases) compared to those without (52 controls). Both groups had a similar mean age (41 vs. 39 years). Around 86% of the participants were non-hospitalized at the time of infection, and none of them were vaccinated at that point. Subsequently, both cases and controls received the vaccine; however, the vaccination rates differed significantly between the groups (30.7% vs. 51.0%). Cases and controls had similar rates of symptoms at acute COVID phase. However, cases were more likely to experience coryza, dyspnea, headache, and nausea/vomiting during long COVID. Regarding new-onset symptoms in long COVID, 12.9% of cases had dyspnea, and 14.5% experienced nausea/vomiting, whereas in the control group there were only 1.9% and 0.0%, respectively. Cases also had a significantly higher prevalence of persistent headache (22.6% vs. 7.7%), and dyspnea (12.9% vs. 0.0). In addition, cases also showed an increased rate of mental health complaints: disability in daily activities (45.2% vs. 9.6%; P < 0.001); concentration/sustained attention difficulties (74.2% vs. 9.6%; P < 0.001); anxiety-Generalized Anxiety Disorder 2-item scale (GAD-2) ≥ 3 (66.1% vs. 34.6%; P = 0.0013); and "post-COVID sadness" (82.3% vs. 40.4%; P < 0.001). We observed a significant correlation between sadness and anxiety in cases, which was not observed in controls (P=0.0212; Spearman correlation test). Furthermore, the frequency of concomitant sadness and anxiety was markedly higher in cases compared to controls (59.7% vs. 19.2%) (P < 0.0001; Mann-Whitney test). These findings highlight a noteworthy association between sadness and anxiety specifically in cases. In conclusion, our data identified concurrent psychological phenotypes in individuals experiencing sleep and memory disturbances during long COVID. This strengthens the existing evidence that SARS-CoV-2 causes widespread brain pathology with interconnected phenotypic clusters. This finding highlights the need for comprehensive medical attention to address these complex issues, as well as major investments in testing strategies capable of preventing the development of long COVID sequelae, such as vaccination.
Collapse
Affiliation(s)
- Ricardo Titze-de-Almeida
- Central Institute of Sciences, Research Center for Major Themes, University of Brasília, Brasília, DF, Brazil
- University of Brasília/FAV, Central Institute of Sciences, Technology for Gene Therapy Laboratory, Brasília, DF, Brazil
| | | | - Edson Pereira de Oliveira
- Central Institute of Sciences, Research Center for Major Themes, University of Brasília, Brasília, DF, Brazil
| | | | | | - Amanda Machado Costa
- Central Institute of Sciences, Research Center for Major Themes, University of Brasília, Brasília, DF, Brazil
| | - Eloísa Pereira Dos Santos
- Central Institute of Sciences, Research Center for Major Themes, University of Brasília, Brasília, DF, Brazil
| | - Louise Marie Coelho Guérard
- Central Institute of Sciences, Research Center for Major Themes, University of Brasília, Brasília, DF, Brazil
| | | | | | | | - Gabriel Ginani Ferreira
- Central Institute of Sciences, Research Center for Major Themes, University of Brasília, Brasília, DF, Brazil
- University of Brasília/FAV, Central Institute of Sciences, Technology for Gene Therapy Laboratory, Brasília, DF, Brazil
| | - Simoneide Souza Titze-de-Almeida
- Central Institute of Sciences, Research Center for Major Themes, University of Brasília, Brasília, DF, Brazil
- University of Brasília/FAV, Central Institute of Sciences, Technology for Gene Therapy Laboratory, Brasília, DF, Brazil
| | - Pedro Renato de Paula Brandão
- Central Institute of Sciences, Research Center for Major Themes, University of Brasília, Brasília, DF, Brazil
- Sírio-Libanês Hospital, Brasília, Brazil., Brasília, DF, Brazil
| | - Helena Eri Shimizu
- Department of Collective Health, Research Center for Major Themes, University of Brasília, Brasília, DF, Brazil
| | - Andrezza Paula Brito Silva
- Central Institute of Sciences, Research Center for Major Themes, University of Brasília, Brasília, DF, Brazil
| | | |
Collapse
|
18
|
Banho CA, de Carvalho Marques B, Sacchetto L, Sepedro Lima AK, Pereira Parra MC, Jeronimo Lima AR, Ribeiro G, Jorge Martins A, dos Santos Barros CR, Carolina Elias M, Coccuzzo Sampaio S, Nanev Slavov S, Strazza Rodrigues E, Vieira Santos E, Tadeu Covas D, Kashima S, Augusto Brassaloti R, Petry B, Gaspar Clemente L, Lehmann Coutinho L, Akemi Assato P, da Silva da Costa FA, Souza-Neto JA, Maria Tommasini Grotto R, Daiana Poleti M, Cristina Chagas Lesbon J, Chicaroni Mattos E, Fukumasu H, Giovanetti M, Carlos Junior Alcantara L, Rahal P, Pessoa Araújo JF, Althouse BM, Vasilakis N, Lacerda Nogueira M. Dynamic clade transitions and the influence of vaccine rollout on the spatiotemporal circulation of SARS-CoV-2 variants in São Paulo, Brazil. RESEARCH SQUARE 2024:rs.3.rs-3788142. [PMID: 38343798 PMCID: PMC10854302 DOI: 10.21203/rs.3.rs-3788142/v1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Indexed: 02/21/2024]
Abstract
Since 2021, the emergence of variants of concern (VOC) has led Brazil to experience record numbers of in COVID-19 cases and deaths. The expanded spread of the SARS-CoV-2 combined with a low vaccination rate has contributed to the emergence of new mutations that may enhance viral fitness, leading to the persistence of the disease. Due to limitations in the real-time genomic monitoring of new variants in some Brazilian states, we aimed to investigate whether genomic surveillance, coupled with epidemiological data and SARS-CoV-2 variants spatiotemporal spread in a smaller region, can reflect the pandemic progression at a national level. Our findings revealed three SARS-CoV-2 variant replacements from 2021 to early 2022, corresponding to the introduction and increase in the frequency of Gamma, Delta, and Omicron variants, as indicated by peaks of the Effective Reproductive Number (Reff). These distinct clade replacements triggered two waves of COVID-19 cases, influenced by the increasing vaccine uptake over time. Our results indicated that the effectiveness of vaccination in preventing new cases during the Delta and Omicron circulations was six and eleven times higher, respectively, than during the period when Gamma was predominant, and it was highly efficient in reducing the number of deaths. Furthermore, we demonstrated that genomic monitoring at a local level can reflect the national trends in the spread and evolution of SARS-CoV-2.
Collapse
Affiliation(s)
- Cecília Artico Banho
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
| | - Beatriz de Carvalho Marques
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
| | - Lívia Sacchetto
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
| | - Ana Karoline Sepedro Lima
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
| | - Maisa Carla Pereira Parra
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
| | - Alex Ranieri Jeronimo Lima
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
| | - Gabriela Ribeiro
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
| | - Antonio Jorge Martins
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
| | | | - Maria Carolina Elias
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
| | - Sandra Coccuzzo Sampaio
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
| | - Svetoslav Nanev Slavov
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
- University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil
| | - Evandra Strazza Rodrigues
- University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil
| | - Elaine Vieira Santos
- University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil
| | - Dimas Tadeu Covas
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo, Brazil
- University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil
| | - Simone Kashima
- University of São Paulo, Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, Ribeirão Preto, SP, Brazil
| | | | - Bruna Petry
- University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil
| | - Luan Gaspar Clemente
- University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil
| | - Luiz Lehmann Coutinho
- University of São Paulo, Centro de Genômica Funcional da ESALQ, Piracicaba, SP, Brazil
| | - Patricia Akemi Assato
- São Paulo State University (UNESP), School of Agricultural Sciences, Department of Bioprocesses and Biotechnology, Botucatu, Brazil
| | - Felipe Allan da Silva da Costa
- São Paulo State University (UNESP), School of Agricultural Sciences, Department of Bioprocesses and Biotechnology, Botucatu, Brazil
| | - Jayme A. Souza-Neto
- São Paulo State University (UNESP), School of Agricultural Sciences, Botucatu, Brazil
| | - Rejane Maria Tommasini Grotto
- São Paulo State University (UNESP), School of Agricultural Sciences, Botucatu, Brazil
- Molecular Biology Laboratory, Applied Biotechnology Laboratory, Clinical Hospital of the Botucatu Medical School, Brazil
| | - Mirele Daiana Poleti
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil
| | - Jessika Cristina Chagas Lesbon
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil
| | - Elisangela Chicaroni Mattos
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil
| | - Heidge Fukumasu
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of São Paulo, Pirassununga, São Paulo, Brazil
| | - Marta Giovanetti
- Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, Brazil
- Climate Amplified Diseases And Epidemics (CLIMADE), Brazil, Americas
- Sciences and Technologies for Sustainable Development and One Health, Universita Campus Bio-Medico di Roma, Italy
| | - Luiz Carlos Junior Alcantara
- Oswaldo Cruz Foundation, FIOCRUZ, Rio de Janeiro, Brazil
- Climate Amplified Diseases And Epidemics (CLIMADE), Brazil, Americas
| | - Paula Rahal
- Laboratório de Estudos Genômicos, Departamento de Biologia, Instituto de Biociências Letras e Ciências Exatas (IBILCE), Universidade Estadual Paulista (Unesp), São José do Rio Preto, Brazil
| | - João Fernando Pessoa Araújo
- Instituto de Biotecnologia, Universidade Estadual Paulista (Unesp), Botucatu, Brazil
- Laboratório de Microbiologia Molecular, Instituto de Ciências da Saúde, Universidade Feevale, Novo Hamburgo, Brazil
| | - Benjamin M. Althouse
- Department of Biology, New Mexico State University, Las Cruces, NM
- Information School, University of Washington, Seattle, WA
| | - Nikos Vasilakis
- Department of Pathology, University of Texas Medical Branch; Galveston, Texas, United States of America
- Center for Vector-Borne and Zoonotic Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America
- Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, Texas, United States of America
| | - Maurício Lacerda Nogueira
- Laboratório de Pesquisas em Virologia, Faculdade de Medicina de São José do Rio Preto; São José do Rio Preto, São Paulo, Brazil
- Department of Pathology, University of Texas Medical Branch; Galveston, Texas, United States of America
| |
Collapse
|
19
|
Chen Z, Lemey P, Yu H. Approaches and challenges to inferring the geographical source of infectious disease outbreaks using genomic data. THE LANCET. MICROBE 2024; 5:e81-e92. [PMID: 38042165 DOI: 10.1016/s2666-5247(23)00296-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/13/2023] [Revised: 09/03/2023] [Accepted: 09/13/2023] [Indexed: 12/04/2023]
Abstract
Genomic data hold increasing potential in the elucidation of transmission dynamics and geographical sources of infectious disease outbreaks. Phylogeographic methods that use epidemiological and genomic data obtained from surveillance enable us to infer the history of spatial transmission that is naturally embedded in the topology of phylogenetic trees as a record of the dispersal of infectious agents between geographical locations. In this Review, we provide an overview of phylogeographic approaches widely used for reconstructing the geographical sources of outbreaks of interest. These approaches can be classified into ancestral trait or state reconstruction and structured population models, with structured population models including popular structured coalescent and birth-death models. We also describe the major challenges associated with sequencing technologies, surveillance strategies, data sharing, and analysis frameworks that became apparent during the generation of large-scale genomic data in recent years, extending beyond inference approaches. Finally, we highlight the role of genomic data in geographical source inference and clarify how this enhances understanding and molecular investigations of outbreak sources.
Collapse
Affiliation(s)
- Zhiyuan Chen
- School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China
| | - Philippe Lemey
- Department of Microbiology, Immunology and Transplantation, Rega Institute, Laboratory of Clinical and Evolutionary Virology, KU Leuven, Leuven, Belgium
| | - Hongjie Yu
- School of Public Health, Fudan University, Key Laboratory of Public Health Safety, Ministry of Education, Shanghai, China.
| |
Collapse
|
20
|
Ferrareze PAG, Cybis GB, de Oliveira LFV, Zimerman RA, Schiavon DEB, Peter C, Thompson CE. Intense P.1 (Gamma) diversification followed by rapid Delta substitution in Southern Brazil: a SARS-CoV-2 genomic epidemiology study. Microbes Infect 2024; 26:105216. [PMID: 37827275 DOI: 10.1016/j.micinf.2023.105216] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Revised: 08/30/2023] [Accepted: 09/03/2023] [Indexed: 10/14/2023]
Abstract
The analyses of genetic traits, dispersion patterns and phylogenomics are essential for understanding the evolutionary forces driving SARS-CoV-2 viruses in these three years of COVID-19 pandemics. Brazil is one of the most affected countries in the world and not sufficient genomic studies have been performed. The emergence of P.1 lineage led to one of the most serious public health crises on record. Our study presents the genomic sequencing and characterization of 412 samples from Rio Grande do Sul state, in the Brazilian Southern region, during Gamma and Delta epidemic waves, in 2021. Additionally, molecular evolution tests were performed to identify positively selected sites in Brazil between 2020 and 2022, as well as offer some evolutionary perspective about the maintenance of multiple spike mutations in Omicron lineages. Genomic epidemiology analysis has indicated an intense P.1 (Gamma) diversification followed by rapid Delta substitution in Southern Brazil.
Collapse
Affiliation(s)
- Patrícia Aline Gröhs Ferrareze
- Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil
| | - Gabriela Betella Cybis
- Department of Statistics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil
| | | | | | - Dieine Estela Bernieri Schiavon
- Undergraduate Program in Biomedical Informatics, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, Rio Grande do Sul, Brazil
| | | | - Claudia Elizabeth Thompson
- Graduate Program in Health Sciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil; Department of Pharmacosciences, Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Porto Alegre, RS, Brazil.
| |
Collapse
|
21
|
Xavier J, Fonseca V, Adelino T, Iani FCM, Pereira GC, Duarte MM, Lima M, Castro E, Oliveira C, Fritsch H, Guimarães N, Lamounier LO, Barreto FK, Braga de Oliveira CMM, Maymone Gonçalves CC, Malta Lima D, de Oliveira EC, de Castro Lichs GG, Gomes I, Mazaro J, Rodrigues JTN, Abrantes J, Colares JKB, Luz KG, Barbosa da Silva L, Demarchi L, Câmara MCB, Umaki Zardin MCS, Sabatini Mello Pinheiro R, Barbosa Souza R, Haddad SK, Figueiredo da Silva S, Slavov SN, Rocha T, Morel N, Chiparelli H, Burgueño A, Bórmida V, Cortinas MN, Martín RS, Pereira AC, dos Santos MF, André Júnior W, Mendez Rico J, Franco L, Rosewell A, do Carmo Said RF, de Albuquerque CFC, Noia Maciel EL, Santini de Oliveira M, Venâncio da Cunha R, Vinhal Frutuoso LC, de Filippis AMB, Giovanetti M, Carlos Junior Alcantara L. A Multiplex Nanopore Sequencing Approach for the Detection of Multiple Arboviral Species. Viruses 2023; 16:23. [PMID: 38257724 PMCID: PMC10821003 DOI: 10.3390/v16010023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2023] [Revised: 12/08/2023] [Accepted: 12/10/2023] [Indexed: 01/24/2024] Open
Abstract
The emergence and continued geographic expansion of arboviruses and the growing number of infected people have highlighted the need to develop and improve multiplex methods for rapid and specific detection of pathogens. Sequencing technologies are promising tools that can help in the laboratory diagnosis of conditions that share common symptoms, such as pathologies caused by emerging arboviruses. In this study, we integrated nanopore sequencing and the advantages of reverse transcription polymerase chain reaction (RT-PCR) to develop a multiplex RT-PCR protocol for the detection of Chikungunya virus (CHIKV) and several orthoflaviviruses (such as dengue (Orthoflavivirus dengue), Zika (Orthoflavivirus zikaense), yellow fever (Orthoflavivirus flavi), and West Nile (Orthoflavivirus nilense) viruses) in a single reaction, which provides data for sequence-based differentiation of arbovirus lineages.
Collapse
Affiliation(s)
- Joilson Xavier
- Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Vagner Fonseca
- Organização Pan-Americana da Saúde, Organização Mundial da Saúde, Brasília 70800-400, Brazil
| | - Talita Adelino
- Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, Brazil (F.C.M.I.)
| | - Felipe C. M. Iani
- Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, Brazil (F.C.M.I.)
| | - Glauco C. Pereira
- Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, Brazil (F.C.M.I.)
| | - Myrian M. Duarte
- Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, Brazil (F.C.M.I.)
| | - Mauricio Lima
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Brazil
| | - Emerson Castro
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Brazil
| | - Carla Oliveira
- lnstituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil
| | - Hegger Fritsch
- Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Natalia Guimarães
- Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, Brazil (F.C.M.I.)
| | - Ludmila O. Lamounier
- Laboratorio Central de Saúde Pública do Estado de Minas Gerais, Fundação Ezequiel Dias, Belo Horizonte 30510-010, Brazil (F.C.M.I.)
| | - Fernanda Khouri Barreto
- Instituto Multidisciplinar em Saúde, Universidade Federal da Bahia, Vitória da Conquista 45029-094, Brazil
| | | | | | - Danielle Malta Lima
- Faculty of the Graduate Program in Biotechnology (Renorbio), Universidade de Fortaleza, Fortaleza 60811-905, Brazil
| | | | | | - Iago Gomes
- Laboratório Central de Saúde Pública do Rio Grande do Norte, Natal 59037-170, Brazil
| | - Janaina Mazaro
- Secretaria Estadual de Saúde do estado do Acre, Rio Branco 69900-064, Brazil
| | | | - Jayra Abrantes
- Laboratório Central de Saúde Pública do Rio Grande do Norte, Natal 59037-170, Brazil
| | - Jeová K. B. Colares
- Faculty of the Graduate Program in Biotechnology (Renorbio), Universidade de Fortaleza, Fortaleza 60811-905, Brazil
| | - Kleber G. Luz
- Department of Infectious Diseases, Universidade Federal do Rio Grande do Norte, Natal 59078-900, Brazil
| | | | - Luiz Demarchi
- Laboratorio Central de Saúde Pública do Mato Grosso do Sul, Campo Grande 79074-460, Brazil
| | - Magaly C. B. Câmara
- Laboratório Central de Saúde Pública do Rio Grande do Norte, Natal 59037-170, Brazil
| | | | | | | | - Simone K. Haddad
- Fundação Hemocentro de Ribeirão Preto, Ribeirão Preto 14051-140, Brazil
| | | | | | - Themis Rocha
- Laboratório Central de Saúde Pública do Rio Grande do Norte, Natal 59037-170, Brazil
| | - Noelia Morel
- Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo 11200, Uruguay
| | - Hector Chiparelli
- Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo 11200, Uruguay
| | - Analía Burgueño
- Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo 11200, Uruguay
| | - Victoria Bórmida
- Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo 11200, Uruguay
| | - María N. Cortinas
- Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo 11200, Uruguay
| | - Rosario S. Martín
- Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo 11200, Uruguay
| | | | | | | | | | - Leticia Franco
- Pan American Health Organization, Washington, DC 20037, USA
| | - Alexander Rosewell
- Organização Pan-Americana da Saúde, Organização Mundial da Saúde, Brasília 70800-400, Brazil
| | | | | | - Ethel L. Noia Maciel
- Secretaria de Vigilância em Saúde e Ambiente, Ministério da Saúde, Brasília 70058-900, Brazil
| | | | | | | | | | - Marta Giovanetti
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Brazil
- Sciences and Technologies for Sustainable Development and One Health, Universita Campus Bio-Medico di Roma, 00128 Roma, Italy
- Climate Amplified Diseases and Epidemics (CLIMADE), Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Brazil
| | - Luiz Carlos Junior Alcantara
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Brazil
- Climate Amplified Diseases and Epidemics (CLIMADE), Fundação Oswaldo Cruz, Belo Horizonte 30190-002, Brazil
| |
Collapse
|
22
|
de Oliveira LA, dos Santos Barbosa M, Leite Torres AJ, Croda MG, Oliveira da Silva B, dos Santos PCP, Rossoni R, Machado LOCL, Croda J, Maymone Gonçalves CC, Marques MF, da Silva Ferreira T, Sardi SI, Campos GS, de Almeida GB, Alves Gomes MM, Marchioro SB, Simionatto S. Seroprevalence Of SARS-COV-2 infection in asymptomatic indigenous from the largest Brazilian periurban area. PLoS One 2023; 18:e0295211. [PMID: 38134187 PMCID: PMC10745159 DOI: 10.1371/journal.pone.0295211] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2023] [Accepted: 11/15/2023] [Indexed: 12/24/2023] Open
Abstract
This study assessed the seroprevalence of SARS-CoV-2 in 496 asymptomatic individuals from Mato Grosso do Sul, located in Dourados, the largest periurban indigenous area in Brazil, from January 25 to February 4, 2021. The volunteers participated before receiving their first dose of the CoronaVac inactivated vaccine. For screening, blood samples were collected and analyzed using SARS-CoV-2 rapid tests and the enzyme-linked immunosorbent assay (ELISA). We observed varying trends in total anti-SARS-CoV-2 antibodies across different variables. Seropositivity among the participants tested was 63.70% (316/496) using the rapid test and 52.82% (262/496) were positive using the ELISA method. The majority of participants identified with the Guarani-Kaiowá ethnic group, with 66.15% (217/328), and other ethnic groups with 58.84% (193/328). The median age of the subjects was 30.5 years, with 79.57% (261/328) being femaleThis research showed the elevated seroprevalence of SARS-CoV-2 antibodies in asymptomatic Brazilians. The findings indicate a high seropositivity rate among the asymptomatic indigenous population of Midwest Brazil. This underscores the overlooked status of these communities and underscores the need for targeted national initiatives that emphasize the protection of vulnerable ethnic groups in the fight against COVID-19.
Collapse
Affiliation(s)
| | - Marcelo dos Santos Barbosa
- Health Science Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| | - Alex José Leite Torres
- Laboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil
| | - Mariana Garcia Croda
- School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Bruna Oliveira da Silva
- Health Science Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| | | | - Regina Rossoni
- Health Science Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| | | | - Julio Croda
- School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
- Oswaldo Cruz Foundation, Campo Grande, Mato Grosso do Sul, Brazil
| | - Crhistinne Cavalheiro Maymone Gonçalves
- School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
- State Secretariat of Health of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Michele Ferreira Marques
- Health Science Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| | - Tiago da Silva Ferreira
- Health Science Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| | - Silvia Inês Sardi
- Laboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil
| | - Gubio Soares Campos
- Laboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil
| | - Gabriel Barroso de Almeida
- Laboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil
| | - Marilia Maria Alves Gomes
- Health Science Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| | - Silvana Beutinger Marchioro
- Laboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil
| | - Simone Simionatto
- Health Science Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| |
Collapse
|
23
|
Freitas MTDS, Sena LOC, Fukutani KF, dos Santos CA, Neto FDCB, Ribeiro JS, dos Reis ES, Balbino VDQ, de Sá Paiva Leitão S, de Aragão Batista MV, Lipscomb MW, de Moura TR. The increase in SARS-CoV-2 lineages during 2020-2022 in a state in the Brazilian Northeast is associated with a number of cases. Front Public Health 2023; 11:1222152. [PMID: 38186707 PMCID: PMC10771345 DOI: 10.3389/fpubh.2023.1222152] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2023] [Accepted: 11/15/2023] [Indexed: 01/09/2024] Open
Abstract
SARS-CoV-2 has caused a high number of deaths in several countries. In Brazil, there were 37 million confirmed cases of COVID-19 and 700,000 deaths caused by the disease. The population size and heterogeneity of the Brazilian population should be considered in epidemiological surveillance due to the varied tropism of the virus. As such, municipalities and states must be factored in for their unique specificities, such as socioeconomic conditions and population distribution. Here, we investigate the spatiotemporal dispersion of emerging SARS-CoV-2 lineages and their dynamics in each microregion from Sergipe state, northeastern Brazil, in the first 3 years of the pandemic. We analyzed 586 genomes sequenced between March 2020 and November 2022 extracted from the GISAID database. Phylogenetic analyses were carried out for each data set to reconstruct evolutionary history. Finally, the existence of a correlation between the number of lineages and infection cases by SARS-CoV-2 was evaluated. Aracaju, the largest city in northeastern Brazil, had the highest number of samples sequenced. This represented 54.6% (320) of the genomes, and consequently, the largest number of lineages identified. Studies also analyzed the relationship between mean lineage distributions and mean monthly infections, daily cases, daily deaths, and hospitalizations of vaccinated and unvaccinated patients. For this, a correlation matrix was created. Results revealed that the increase in the average number of SARS-CoV-2 variants was related to the average number of SARS-CoV-2 cases in both unvaccinated and vaccinated individuals. Thus, our data indicate that it is necessary to maintain epidemiological surveillance, especially in capital cities, since they have a high rate of circulation of resident and non-resident inhabitants, which contributes to the dynamics of the virus.
Collapse
Affiliation(s)
- Moises Thiago de Souza Freitas
- Health Sciences Graduate Program, Federal University of Sergipe, Aracaju, Brazil
- Parasitic Biology Graduate Program, Federal University of Sergipe, São Cristóvão, Brazil
| | - Ludmila Oliveira Carvalho Sena
- Health Foundation Parreiras Horta, Central Laboratory of Public Health (LACEN/SE), Sergipe State Health Secretariat, Aracaju, Brazil
| | - Kiyoshi Ferreira Fukutani
- Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, NH, United States
| | - Cliomar Alves dos Santos
- Health Foundation Parreiras Horta, Central Laboratory of Public Health (LACEN/SE), Sergipe State Health Secretariat, Aracaju, Brazil
| | | | - Julienne Sousa Ribeiro
- Center for Biological and Health Sciences, Federal University of Sergipe, São Cristóvão, Brazil
| | | | | | | | | | | | | |
Collapse
|
24
|
Trovao NS, Pan V, Goel C, Gallego-García P, Liu Y, Barbara C, Borg R, Briffa M, Cilia C, Grech L, Vassallo M, Treangen TJ, Posada D, Beheshti A, Borg J, Zahra G. Evolutionary and spatiotemporal analyses reveal multiple introductions and cryptic transmission of SARS-CoV-2 VOC/VOI in Malta. Microbiol Spectr 2023; 11:e0153923. [PMID: 37800925 PMCID: PMC10714767 DOI: 10.1128/spectrum.01539-23] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2023] [Accepted: 08/13/2023] [Indexed: 10/07/2023] Open
Abstract
IMPORTANCE Our study provides insights into the evolution of the coronavirus disease 2019 (COVID-19) pandemic in Malta, a highly connected and understudied country. We combined epidemiological and phylodynamic analyses to analyze trends in the number of new cases, deaths, tests, positivity rates, and evolutionary and dispersal patterns from August 2020 to January 2022. Our reconstructions inferred 173 independent severe acute respiratory syndrome coronavirus 2 introductions into Malta from various global regions. Our study demonstrates that characterizing epidemiological trends coupled with phylodynamic modeling can inform the implementation of public health interventions to help control COVID-19 transmission in the community.
Collapse
Affiliation(s)
- Nidia S. Trovao
- Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA
- COVID-19 International Research Team, Medford, Massachusetts, USA
| | - Vincent Pan
- Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA
- Harvard University, Cambridge, Massachusetts, USA
| | - Chirag Goel
- COVID-19 International Research Team, Medford, Massachusetts, USA
- Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA
| | - Pilar Gallego-García
- CINBIO, Universidade de Vigo, Vigo, Spain
- Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain
| | - Yunxi Liu
- Department of Computer Science, Rice University, Houston, Texas, USA
| | - Christopher Barbara
- Molecular Diagnostics-Infectious Diseases, Department of Pathology, Mater Dei Hospital, Msida, Malta
| | - Rebecca Borg
- Molecular Diagnostics-Infectious Diseases, Department of Pathology, Mater Dei Hospital, Msida, Malta
| | - Mark Briffa
- Molecular Diagnostics-Infectious Diseases, Department of Pathology, Mater Dei Hospital, Msida, Malta
| | - Chanelle Cilia
- Molecular Diagnostics-Infectious Diseases, Department of Pathology, Mater Dei Hospital, Msida, Malta
| | - Laura Grech
- Molecular Diagnostics-Infectious Diseases, Department of Pathology, Mater Dei Hospital, Msida, Malta
| | - Mario Vassallo
- Department of Sociology, Faculty of Arts, University of Malta, Msida, Malta
| | - Todd J. Treangen
- Department of Computer Science, Rice University, Houston, Texas, USA
| | - David Posada
- CINBIO, Universidade de Vigo, Vigo, Spain
- Galicia Sur Health Research Institute (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Spain
- Department of Biochemistry, Genetics, and Immunology, Universidade de Vigo, Vigo, Spain
| | - Afshin Beheshti
- COVID-19 International Research Team, Medford, Massachusetts, USA
- Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA
- KBR, Space Biosciences Division, NASA Ames Research Center, Moffett Field, California, USA
| | - Joseph Borg
- COVID-19 International Research Team, Medford, Massachusetts, USA
- Department of Applied Biomedical Science, Faculty of Health Sciences, University of Malta, Msida, Malta
| | - Graziella Zahra
- Molecular Diagnostics-Infectious Diseases, Department of Pathology, Mater Dei Hospital, Msida, Malta
| |
Collapse
|
25
|
Andreis TF, Cantarelli VV, da Silva MB, Helfer MS, Brust FR, Zavascki AP. Substantial Diversity in Cocirculating Omicron Lineages in Hospital Setting, Porto Alegre, Brazil. Emerg Infect Dis 2023; 29:2583-2586. [PMID: 37966098 PMCID: PMC10683828 DOI: 10.3201/eid2912.230880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2023] Open
Abstract
We describe substantial variant diversity among 23 detected SARS-CoV-2 Omicron lineage viruses cocirculating among healthcare workers and inpatients (272 sequenced samples) from Porto Alegre, Brazil, during November 2022-January 2023. BQ.1 and related lineages (61.4%) were most common, followed by BE.9 (19.1%), first described in November 2022 in the Amazon region.
Collapse
|
26
|
Slavov SN, Lima ARJ, Ribeiro G, de Lima LPO, Barros CRDS, Marqueze EC, Martins AJ, Martininghi M, Palmieri M, Caldeira LAV, da Silva FEV, Cacherik G, Nicolodelli AL, Kashima S, Giovanetti M, Alcantara LCJ, Sampaio SC, Elias MC. Epidemiological and Genomic Analysis of Asymptomatic SARS-CoV-2 Infections during the Delta and Omicron Epidemic Waves in São Paulo City, Brazil. Viruses 2023; 15:2210. [PMID: 38005887 PMCID: PMC10675288 DOI: 10.3390/v15112210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2023] [Revised: 10/24/2023] [Accepted: 10/25/2023] [Indexed: 11/26/2023] Open
Abstract
We examined the asymptomatic rates of SARS-CoV-2 infection during the Delta and Omicron waves in the city of São Paulo. Nasopharyngeal swabs were collected at strategic points of the city (open-air markets, bus terminals, airports) for SARS-CoV-2 RNA testing. Applying the questionnaire, the symptomatic individuals were excluded, and only asymptomatic cases were analyzed. During the Delta wave, a total of 4315 samples were collected, whereas 2372 samples were collected during the first Omicron wave. The incidence of the asymptomatic SARS-CoV-2 infection was 0.6% during the Delta wave and 0.8% during the Omicron wave. No statistical differences were found in the threshold amplification cycle. However, there was a statistical difference observed in the sublineage distribution between asymptomatic and symptomatic individuals. Our study determined the incidence of asymptomatic infection by monitoring individuals who remained symptom-free, thereby providing a reliable evaluation of asymptomatic SARS-CoV-2 carriage. Our findings reveal a relatively low proportion of asymptomatic cases, which could be attributed to our rigorous monitoring protocol for the presence of clinical symptoms. Investigating asymptomatic infection rates is crucial to develop and implement effective disease control strategies.
Collapse
Affiliation(s)
- Svetoslav N. Slavov
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo 05507-000, SP, Brazil; (S.N.S.); (A.R.J.L.); (G.R.); (L.P.O.d.L.); (C.R.d.S.B.); (E.C.M.); (A.J.M.)
- Ribeirão Preto Medical School, Ribeirão Preto 14051-140, SP, Brazil;
- Blood Center of Ribeirão Preto, Ribeirão Preto 14051-140, SP, Brazil
| | - Alex R. J. Lima
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo 05507-000, SP, Brazil; (S.N.S.); (A.R.J.L.); (G.R.); (L.P.O.d.L.); (C.R.d.S.B.); (E.C.M.); (A.J.M.)
| | - Gabriela Ribeiro
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo 05507-000, SP, Brazil; (S.N.S.); (A.R.J.L.); (G.R.); (L.P.O.d.L.); (C.R.d.S.B.); (E.C.M.); (A.J.M.)
| | - Loyze P. O. de Lima
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo 05507-000, SP, Brazil; (S.N.S.); (A.R.J.L.); (G.R.); (L.P.O.d.L.); (C.R.d.S.B.); (E.C.M.); (A.J.M.)
| | - Claudia R. dos S. Barros
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo 05507-000, SP, Brazil; (S.N.S.); (A.R.J.L.); (G.R.); (L.P.O.d.L.); (C.R.d.S.B.); (E.C.M.); (A.J.M.)
| | - Elaine C. Marqueze
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo 05507-000, SP, Brazil; (S.N.S.); (A.R.J.L.); (G.R.); (L.P.O.d.L.); (C.R.d.S.B.); (E.C.M.); (A.J.M.)
| | - Antonio J. Martins
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo 05507-000, SP, Brazil; (S.N.S.); (A.R.J.L.); (G.R.); (L.P.O.d.L.); (C.R.d.S.B.); (E.C.M.); (A.J.M.)
| | - Maiara Martininghi
- Health Surveillance Coordination, Municipal Health Department of São Paulo, Coordenadoria de Vigilância em Saúde (COVISA), Secretaria Municipal de São Paulo (SMS SP), São Paulo 01223-010, SP, Brazil; (M.M.); (M.P.); (L.A.V.C.)
| | - Melissa Palmieri
- Health Surveillance Coordination, Municipal Health Department of São Paulo, Coordenadoria de Vigilância em Saúde (COVISA), Secretaria Municipal de São Paulo (SMS SP), São Paulo 01223-010, SP, Brazil; (M.M.); (M.P.); (L.A.V.C.)
| | - Luiz A. V. Caldeira
- Health Surveillance Coordination, Municipal Health Department of São Paulo, Coordenadoria de Vigilância em Saúde (COVISA), Secretaria Municipal de São Paulo (SMS SP), São Paulo 01223-010, SP, Brazil; (M.M.); (M.P.); (L.A.V.C.)
| | - Fabiana E. V. da Silva
- Primary Care Coordination Municipal Health Department of São Paulo, Coordenadoria de Atenção Básica, Secretaria Municipal de São Paulo (SMS SP), São Paulo 01223-010, SP, Brazil; (F.E.V.d.S.); (G.C.); (A.L.N.)
| | - Giselle Cacherik
- Primary Care Coordination Municipal Health Department of São Paulo, Coordenadoria de Atenção Básica, Secretaria Municipal de São Paulo (SMS SP), São Paulo 01223-010, SP, Brazil; (F.E.V.d.S.); (G.C.); (A.L.N.)
| | - Aline L. Nicolodelli
- Primary Care Coordination Municipal Health Department of São Paulo, Coordenadoria de Atenção Básica, Secretaria Municipal de São Paulo (SMS SP), São Paulo 01223-010, SP, Brazil; (F.E.V.d.S.); (G.C.); (A.L.N.)
| | - Simone Kashima
- Ribeirão Preto Medical School, Ribeirão Preto 14051-140, SP, Brazil;
- Blood Center of Ribeirão Preto, Ribeirão Preto 14051-140, SP, Brazil
- University of São Paulo, Ribeirão Preto 14051-140, SP, Brazil
| | - Marta Giovanetti
- Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, MG, Brazil; (M.G.); (L.C.J.A.)
- Institute Rene Rachou Foundation Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil
- Sciences and Technologies for Sustainable Development and One Health, University Campus Bio-Medico Rome, 00128 Roma, Italy
| | - Luiz Carlos Junior Alcantara
- Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270-901, MG, Brazil; (M.G.); (L.C.J.A.)
- Institute Rene Rachou Foundation Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil
| | - Sandra C. Sampaio
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo 05507-000, SP, Brazil; (S.N.S.); (A.R.J.L.); (G.R.); (L.P.O.d.L.); (C.R.d.S.B.); (E.C.M.); (A.J.M.)
| | - Maria C. Elias
- Center for Viral Surveillance and Serological Assessment (CeVIVAS), Butantan Institute, São Paulo 05507-000, SP, Brazil; (S.N.S.); (A.R.J.L.); (G.R.); (L.P.O.d.L.); (C.R.d.S.B.); (E.C.M.); (A.J.M.)
| |
Collapse
|
27
|
de Oliveira LA, de Rezende IM, Navarini VJ, Marchioro SB, Torres AJL, Croda J, Croda MG, Gonçalves CCM, Xavier J, de Castro E, Lima M, Iani F, Adelino T, Aburjaile F, Ferraz Demarchi LH, Taira DL, Zardin MCSU, Fonseca V, Giovanetti M, Andrews J, Alcantara LCJ, Simionatto S. Genomic characterization of SARS-CoV-2 from an indigenous reserve in Mato Grosso do Sul, Brazil. Front Public Health 2023; 11:1195779. [PMID: 37965526 PMCID: PMC10641392 DOI: 10.3389/fpubh.2023.1195779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Accepted: 09/04/2023] [Indexed: 11/16/2023] Open
Abstract
Background The COVID-19 pandemic had a major impact on indigenous populations. Understanding the viral dynamics within this population is essential to create targeted protection measures. Methods A total of 204 SARS-CoV-2 positive samples collected between May 2020 and November 2021 from an indigenous area in Mato Grosso do Sul (MS), Midwestern Brazil, were screened. Samples were submitted to whole genome sequencing using the Nanopore sequencing platform. Clinical, demographic, and phylogenetic data were analyzed. Results We found the co-circulation of six main SARS-CoV-2 lineages in the indigenous population, with the Zeta lineage being the most prevalent (27.66%), followed by B.1.1 (an ancestral strain) (20.21%), Gamma (14.36%) and Delta (13.83%). Other lineages represent 45.74% of the total. Our phylogenetic reconstruction indicates that multiple introduction events of different SARS-CoV-2 lineages occurred in the indigenous villages in MS. The estimated indigenous population mortality rate was 1.47%. Regarding the ethnicity of our cohort, 64.82% belong to the Guarani ethnicity, while 33.16% belong to the Terena ethnicity, with a slightly higher prevalence of males (53.43%) among females. Other ethnicities represent 2.01%. We also observed that almost all patients (89.55%) presented signs and symptoms related to COVID-19, being the most prevalent cough, fever, sore throat, and headache. Discussion Our results revealed that multiple independent SARS-CoV-2 introduction events had occurred through time, probably due to indigenous mobility, since the villages studied here are close to urban areas in MS. The mortality rate was slightly below of the estimation for the state in the period studied, which we believe could be related to the small number of samples evaluated, the underreporting of cases and deaths among this population, and the inconsistency of secondary data available for this study. Conclusion In this study, we showed the circulation of multiple SARS-CoV-2 variants in this population, which should be isolated and protected as they belong to the most fragile group due to their socioeconomic and cultural disparities. We reinforce the need for constant genomic surveillance to monitor and prevent the spread of new emerging viruses and to better understand the viral dynamics in these populations, making it possible to direct specific actions.
Collapse
Affiliation(s)
- Laís Albuquerque de Oliveira
- Health Sciences Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| | - Izabela Mauricio de Rezende
- Stanford Pandemic Preparedness Hub, Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States
| | - Vinicius João Navarini
- Health Sciences Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| | - Silvana Beutinger Marchioro
- Laboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil
| | - Alex José Leite Torres
- Laboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia, Brazil
| | - Julio Croda
- Oswaldo Cruz Foundation, Campo Grande, Mato Grosso do Sul, Brazil
- Faculdade de Medicina (FAMED), Universidade Federal do Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Mariana Garcia Croda
- Faculdade de Medicina (FAMED), Universidade Federal do Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Crhistinne Cavalheiro Maymone Gonçalves
- School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
- State Secretariat of Health of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Joilson Xavier
- Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Emerson de Castro
- Ezequiel Dias Foundation (FUNED), Belo Horizonte, Minas Gerais, Brazil
| | - Mauricio Lima
- Ezequiel Dias Foundation (FUNED), Belo Horizonte, Minas Gerais, Brazil
| | - Felipe Iani
- Ezequiel Dias Foundation (FUNED), Belo Horizonte, Minas Gerais, Brazil
| | - Talita Adelino
- Ezequiel Dias Foundation (FUNED), Belo Horizonte, Minas Gerais, Brazil
| | - Flávia Aburjaile
- Preventive Veterinary Medicine Departament, Veterinary School, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | | | - Deborah Ledesma Taira
- State Secretariat of Health of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | | | - Vagner Fonseca
- Pan American Health Organization - PAHO, Brasília, Distrito Federal, Brazil
| | - Marta Giovanetti
- Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil
- Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Rome, Italy
- Climate-Amplified Diseases and Epidemics (CLIMADE) Rio de Janeiro, Rio de Janeiro, Brazil
| | - Jason Andrews
- Stanford Pandemic Preparedness Hub, Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, United States
| | - Luiz Carlos Junior Alcantara
- Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil
- Climate-Amplified Diseases and Epidemics (CLIMADE) Rio de Janeiro, Rio de Janeiro, Brazil
| | - Simone Simionatto
- Health Sciences Research Laboratory, Federal University of Grande Dourados, Dourados, Mato Grosso do Sul, Brazil
| |
Collapse
|
28
|
da Penha Gomes Gouvea M, Lira Machado KLL, de Oliveira YGP, Moulaz IR, Henriques AG, Gouveia TM, Thompson BP, Lança KEM, de Souza Ramos S, Lacerda GCC, Lenzi JPG, de Castro Pimentel F, Miossi JPM, Rassele ML, Camacho LAB, Villela DAM, de Lima SMB, de Souza Azevedo A, Horbach IS, de Araújo MF, Tort LFL, de Oliveira ACA, Siqueira MM, Garcia CC, da Costa-Rocha IA, Campi-Azevedo AC, Peruhype-Magalhães V, da Silva VG, Miyamoto ST, Dos Santos Fantoni RN, Pinto-Neto LF, Magda Domingues C, de Medeiros Junior NF, Burian AP, Teixeira-Carvalho A, Mota LMH, Mill JG, Martins-Filho OA, Valim V. Timeline kinetics of protective immunity to SARS-CoV-2 upon primary vaccination and humoral response to variants after booster dose. Vaccine 2023; 41:6514-6528. [PMID: 37661534 DOI: 10.1016/j.vaccine.2023.08.022] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/24/2023] [Revised: 08/04/2023] [Accepted: 08/08/2023] [Indexed: 09/05/2023]
Abstract
New variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged, imposing the need for periodic booster doses. However, whether booster doses should be applied to the entire population or groups, and the booster doses interval, remains unclear. In this study, we evaluated humoral reactivity kinetics from before the first dose to 180 days after the third booster dose in different schedules in a well-controlled health worker cohort. Among the 2,506 employees, the first 500 vaccinated health workers were invited to participate. The third booster dose was administered 8 months after the first dose. Among the invited participants, 470 were included in the study; 258 received inactivated vaccine CoronaVac (VAC group) and 212 received viral vector vaccine ChAdOx1 (AZV group). The groups were homogeneous in terms of age and sex. 347 participants were followed up after the booster dose with AZV or BNT162b2 (Pfizer, BNT group): 63 with VAC/AZV, 117 with VAC/BNT, 72 with the AZV/AZV and 95 with AZV/BNT schedules. Blood samples were collected immediately before, 28 days after each dose and 180 days after the primary vaccination and booster dose. Anti-SARS-CoV-2 antibodies were measured by chemiluminescence and plaque reduction neutralization test (PRNT). Plasma immune mediators were quantified using a multiplex immunoassay. Geometric mean of antibodies increased 28 days after the second dose with 100 % seroconversion rate in both groups and decreased 180 days after the first dose. In the baseline-seropositive VAC group, the levels of plasma immune mediators increased after the second dose. Booster dose was applied at 4-6 months after the primary vaccination. Heterologous booster in VAC or AZV primary vaccinees were effective maintaining the titers of anti-SARS-CoV-2 antibodies even after 6 months of follow-up. The heterologous schedule induced higher and stable antibody reactivity, even after 180 days, protecting to ancestral (Wuhan), Delta, and Omicron variants.
Collapse
Affiliation(s)
- Maria da Penha Gomes Gouvea
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil; Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil
| | - Ketty Lysie Libardi Lira Machado
- Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil
| | - Yasmin Gurtler Pinheiro de Oliveira
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil; Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil
| | - Isac Ribeiro Moulaz
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | - Allan Gonçalves Henriques
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | - Thayná Martins Gouveia
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | - Beatriz Paoli Thompson
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | - Karen Evelin Monlevade Lança
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | - Sabrina de Souza Ramos
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | | | - João Pedro Gonçalves Lenzi
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | - Felipe de Castro Pimentel
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | - João Pedro Moraes Miossi
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | - Matheus Leite Rassele
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | | | | | - Sheila Maria Barbosa de Lima
- Laboratório de Tecnologia Virológica (LATEV), Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil
| | - Adriana de Souza Azevedo
- Laboratório de Tecnologia Virológica (LATEV), Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil
| | - Ingrid Siciliano Horbach
- Laboratório de Tecnologia Virológica (LATEV), Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil
| | - Mia Ferreira de Araújo
- Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil
| | - Luis Fernando Lopez Tort
- Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil
| | - Any Caroline Alves de Oliveira
- Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil
| | - Marilda Mendonça Siqueira
- Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil
| | - Cristiana Couto Garcia
- Instituto René Rachou, Fundação Oswaldo Cruz (FIOCRUZ-Minas), Belo Horizonte, MG, Brazil; Laboratório de Vírus Respiratórios, Exantemáticos, Enterovírus e Emergências Virais (LVRE), Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro, RJ, Brazil
| | | | | | | | - Vanézia Gonçalves da Silva
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil; Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil
| | - Samira Tatiyama Miyamoto
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil
| | | | | | - Carla Magda Domingues
- External Consultant, Temporary Consulting of the Pan American Health Organization, Brazil
| | - Nésio Fernandes de Medeiros Junior
- Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil; Secretaria de Saúde do Estado do Espírito Santo, Vitória, ES, Brazil
| | - Ana Paula Burian
- Secretaria de Saúde do Estado do Espírito Santo, Vitória, ES, Brazil
| | | | | | - José Geraldo Mill
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil; Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil
| | | | - Valéria Valim
- Hospital Universitário Cassiano Antônio Moraes, Universidade Federal do Espírito Santo (HUCAM-UFES/EBSERH), Vitória, ES, Brazil; Programa de Pós-graduação em Saúde Coletiva (PPGSC), Centro de Ciências Médicas, Universidade Federal do Espírito Santo, Vitória, ES, Brazil.
| |
Collapse
|
29
|
da Silva FF, de Abreu LC, Daboin BEG, Morais TC, Cavalcanti MPE, Bezerra IMP, da Silva CG, Figueira FAMDS, de Caldas Guedes VV, Perez Riera AR. Temporal Analysis of COVID-19 Epidemiological Indicators in a Low-Income Brazilian Context: A Retrospective Analysis in Paraiba State. Viruses 2023; 15:2016. [PMID: 37896793 PMCID: PMC10611110 DOI: 10.3390/v15102016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2023] [Revised: 09/20/2023] [Accepted: 09/23/2023] [Indexed: 10/29/2023] Open
Abstract
Northeast Brazil is a region with great international tourist potential. Among the states that make up this region, Paraíba stands out due to the presence of vulnerable groups and factors that contribute to adverse outcomes of COVID-19. Therefore, the aim of this study was to analyze the epidemiological data on the incidence, mortality, and case fatality of COVID-19 in Paraíba. An ecological, population-based study was performed, with data extracted from the Brazilian Ministry of Health database. All cases and deaths from COVID-19 from March 2020 to December 2022 were included. The time series was built by applying the Prais-Winsten regression model, and the daily percent change was calculated to analyze the trends. The highest case fatality of the entire period was in April 2020 (7.8%), but in March 2021, the state broke the dismal record of 1248 deaths and the highest mortality rate (30.5 deaths per 100,000 inhabitants). Stationary mortality and case fatality were better in 2022; however, in February 2022, the mortality rate was at levels similar to the same month of the previous year. These results illustrate that COVID-19 is evolving and needs to be constantly monitored.
Collapse
Affiliation(s)
- Fabiola Ferreira da Silva
- Laboratory of Studies Design and Scientific Writing, Postgraduate Division, University Center FMABC, Santo André 09060-870, SP, Brazil; (F.F.d.S.); (L.C.d.A.); (B.E.G.D.); (C.G.d.S.); (A.R.P.R.)
| | - Luiz Carlos de Abreu
- Laboratory of Studies Design and Scientific Writing, Postgraduate Division, University Center FMABC, Santo André 09060-870, SP, Brazil; (F.F.d.S.); (L.C.d.A.); (B.E.G.D.); (C.G.d.S.); (A.R.P.R.)
- Department of Integrated Health Education, Federal University of Espirito Santo, Vitoria 29075-910, ES, Brazil
- School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland
- Post-Graduate Program in Medical Sciences, Faculty of Medicine of the University of São Paulo, São Paulo 01246-903, SP, Brazil; (M.P.E.C.); (F.A.M.d.S.F.)
| | - Blanca Elena Guerrero Daboin
- Laboratory of Studies Design and Scientific Writing, Postgraduate Division, University Center FMABC, Santo André 09060-870, SP, Brazil; (F.F.d.S.); (L.C.d.A.); (B.E.G.D.); (C.G.d.S.); (A.R.P.R.)
- School of Medicine, University of Limerick, V94 T9PX Limerick, Ireland
| | - Tassiane Cristina Morais
- Department of Integrated Health Education, Federal University of Espirito Santo, Vitoria 29075-910, ES, Brazil
- School of Sciences of Santa Casa de Misericórdia de Vitória (EMESCAM), Vitoria 29045-402, ES, Brazil;
| | - Matheus Paiva Emidio Cavalcanti
- Post-Graduate Program in Medical Sciences, Faculty of Medicine of the University of São Paulo, São Paulo 01246-903, SP, Brazil; (M.P.E.C.); (F.A.M.d.S.F.)
| | | | - Célia Guarnieri da Silva
- Laboratory of Studies Design and Scientific Writing, Postgraduate Division, University Center FMABC, Santo André 09060-870, SP, Brazil; (F.F.d.S.); (L.C.d.A.); (B.E.G.D.); (C.G.d.S.); (A.R.P.R.)
| | | | | | - Andres Ricardo Perez Riera
- Laboratory of Studies Design and Scientific Writing, Postgraduate Division, University Center FMABC, Santo André 09060-870, SP, Brazil; (F.F.d.S.); (L.C.d.A.); (B.E.G.D.); (C.G.d.S.); (A.R.P.R.)
| |
Collapse
|
30
|
de Sousa LAF, Ferreira LSDS, Lobato LFL, Ferreira HLDS, Sousa LHDS, Santos VFD, Nunes PRS, Maramaldo CEC, Neto SS, Sampaio HL, Silva FVD, Brito MDC, Lima WKR, Lima CZGPA, Neto LGL. Molecular epidemiology of SARS-CoV-2 variants in circulation in the state of Maranhão, Brazil. J Med Virol 2023; 95:e29092. [PMID: 37724346 DOI: 10.1002/jmv.29092] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/19/2023] [Revised: 08/14/2023] [Accepted: 08/31/2023] [Indexed: 09/20/2023]
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a coronavirus belonging to the beta CoV genus, responsible for SARS in humans, which became known as COVID-19. The emergence of variants of this virus is related to the presence of cases of reinfection, reduced vaccine effectiveness and greater transmission of the virus. Objective: In this study, we evaluated the molecular epidemiology of SARS-CoV-2 lineages circulating in the state of Maranhão. This is a cross-sectional and retrospective epidemiological study of genomic surveillance of SARS-CoV-2. The study comprised of 338 genomes sequenced by the Next Generation Sequencing technique on Illumina's Miseq equipment, submitted to Global Initiative on Sharing Avian Influenza Data, 190 (56.2%) are from samples of female and 148 (43.8%) from male patients. Sequencing performed covered samples of patients aged between 1 and 108 years, with emphasis on the age groups from 30 to 39 years with 15.0% of sequenced genomes and 20 to 29 years with 12.4%. As for the distribution of sequenced genomes by health macro-regions, 285 (84.3%) are from cities in the northern macro-region. We evidenced the circulation of 29 lineages and sub-lineages, four of which belonging to the Delta variant (AY.43, AY.99.1, AY.99.2 and AY.101 responsible for 4.5% of the genomes) and the others belonging to the Omicron variant, with emphasis on: BA.1 and sub-lineages (42.8%); BA.4, BA.5 and sub-lineages (5.3% and 41.1%); the sub-lineages DL.1 and BQ.1 (5% and 2%). A strong genomic surveillance system allows the study of the natural history of the disease, when there is a resurgence of SARS-CoV-2 cases.
Collapse
Affiliation(s)
- Luis Artur Ferreira de Sousa
- Virology Laboratory, Postgraduation Program in Microbial Biology, CEUMA University, UniCEUMA, São Luís, Maranhão, Brazil
- Oswaldo Cruz Institute/Central Public Health Laboratory of Maranhão-IOC/LACEN-MA, São Luís, Maranhão, Brazil
| | | | - Luis Felipe Lima Lobato
- Oswaldo Cruz Institute/Central Public Health Laboratory of Maranhão-IOC/LACEN-MA, São Luís, Maranhão, Brazil
- Postgraduation Program in Tropical Medicine-IOC/FIOCRUZ-RJ, Rio de Janeiro, Brazil
| | | | | | - Valdenice Ferreira Dos Santos
- Post-graduate Programme in Biodiversity and Biotechnology (BIONORTE), CEUMA University, UniCEUMA, São Luís, Maranhão, Brazil
| | - Paulo Ricardo Silva Nunes
- Oswaldo Cruz Institute/Central Public Health Laboratory of Maranhão-IOC/LACEN-MA, São Luís, Maranhão, Brazil
| | | | - Sebastião Silveira Neto
- Oswaldo Cruz Institute/Central Public Health Laboratory of Maranhão-IOC/LACEN-MA, São Luís, Maranhão, Brazil
| | - Hellen Lobato Sampaio
- Virology Laboratory, Postgraduation Program in Microbial Biology, CEUMA University, UniCEUMA, São Luís, Maranhão, Brazil
| | - Fabiano Vieira da Silva
- Oswaldo Cruz Institute/Central Public Health Laboratory of Maranhão-IOC/LACEN-MA, São Luís, Maranhão, Brazil
- Postgraduation Program in Tropical Medicine-IOC/FIOCRUZ-RJ, Rio de Janeiro, Brazil
| | - Marcelo da Costa Brito
- Oswaldo Cruz Institute/Central Public Health Laboratory of Maranhão-IOC/LACEN-MA, São Luís, Maranhão, Brazil
| | - Washington Kleber Rodrigues Lima
- Post-graduate Programme in Biodiversity and Biotechnology (BIONORTE), CEUMA University, UniCEUMA, São Luís, Maranhão, Brazil
- UniCEUMA, CEUMA University, São Luís, Maranhão, Brazil
| | | | - Lidio Gonçalves Lima Neto
- Virology Laboratory, Postgraduation Program in Microbial Biology, CEUMA University, UniCEUMA, São Luís, Maranhão, Brazil
- Oswaldo Cruz Institute/Central Public Health Laboratory of Maranhão-IOC/LACEN-MA, São Luís, Maranhão, Brazil
| |
Collapse
|
31
|
da Silva NS, de Araújo NK, Dos Santos KA, de Souza KSC, de Araújo JNG, Cruz MS, Parra EJ, Silbiger VN, Luchessi AD. Post-Covid condition and clinic characteristics associated with SARS-CoV-2 infection: a 2-year follow-up to Brazilian cases. Sci Rep 2023; 13:13973. [PMID: 37633999 PMCID: PMC10460396 DOI: 10.1038/s41598-023-40586-8] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2023] [Accepted: 08/13/2023] [Indexed: 08/28/2023] Open
Abstract
Until January 2023, Brazil recorded 37 million COVID-19 cases despite the decrease in mortality due to mass vaccination efforts against COVID-19. The infection continues to challenge researchers and health professionals with the persistent symptoms and onset manifestations after the acute phase of the disease, namely Post-Covid Condition (PCC). Being one of the countries with the highest infection rate, Brazil must prepare for a growing number of patients with chronic health consequences of COVID-19. Longitudinal studies that follow patients over extended periods are crucial in understanding the long-term impacts of COVID-19, including potential health consequences and the effects on quality of life. We describe the clinical profile of a cohort of COVID-19 patients infected during the first year of the pandemic in Brazil and a follow-up after two years to investigate the health impacts of SARS-CoV-2 infection. The first wave of SARS-CoV-2 infection in Brazil featured extensive drug misuse, notably the ineffective COVID kit comprised of ivermectin, antimalarials and azithromycin, and elevated in-hospital mortality. In the second phase of the study, Post-Covid Condition was reported by symptomatic COVID-19 subjects across different severity levels two years after infection. Long haulers are more likely to be women, previously hospitalized, and reported a range of symptoms from muscle pain to cognitive deficit. Our longitudinal study is essential to inform public health authorities to develop strategies and policies to control the spread of the virus and mitigate its impacts on society.
Collapse
Affiliation(s)
- Nayara Sousa da Silva
- Northeast Biotechnology Network (RENORBIO), Graduate Program in Biotechnology, Federal University of Rio Grande do Norte, Natal, Brazil
| | - Nathália Kelly de Araújo
- Graduate Program of Health and Sciences, Federal University of Rio Grande do Norte, Natal, Brazil
- Department of Biological Sciences, Federal Institute of Rondônia, Guajará-Mirim, Brazil
| | - Katiusse Alves Dos Santos
- Graduate Program of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil
| | | | - Jéssica Nayara Góes de Araújo
- Northeast Biotechnology Network (RENORBIO), Graduate Program in Biotechnology, Federal University of Rio Grande do Norte, Natal, Brazil
| | - Marina Sampaio Cruz
- Graduate Program of Health and Sciences, Federal University of Rio Grande do Norte, Natal, Brazil
- Division of Cardiology, Department of Medicine, UC San Diego, San Diego, CA, USA
| | - Esteban J Parra
- Department of Anthropology, University of Toronto at Mississauga, Mississauga, ON, Canada
| | - Vivian Nogueira Silbiger
- Northeast Biotechnology Network (RENORBIO), Graduate Program in Biotechnology, Federal University of Rio Grande do Norte, Natal, Brazil.
- Graduate Program of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil.
- Department of Clinical and Toxicology Analysis, Federal University of Rio Grande do Norte, Av. General Gustavo Cordeiro de Farias, 384, Natal, RN, 59012-570, Brazil.
| | - André Ducati Luchessi
- Northeast Biotechnology Network (RENORBIO), Graduate Program in Biotechnology, Federal University of Rio Grande do Norte, Natal, Brazil
- Graduate Program of Health and Sciences, Federal University of Rio Grande do Norte, Natal, Brazil
- Graduate Program of Pharmaceutical Sciences, Federal University of Rio Grande do Norte, Natal, Brazil
- Department of Clinical and Toxicology Analysis, Federal University of Rio Grande do Norte, Av. General Gustavo Cordeiro de Farias, 384, Natal, RN, 59012-570, Brazil
| |
Collapse
|
32
|
Castilho de Arruda LD, Giovanetti M, Fonseca V, Zardin MCSU, Lichs GGDC, Asato S, Esposito AOP, Tokeshi Müller M, Xavier J, Fritsch H, Lima M, de Oliveira C, Santos EV, Maziero LDMA, Frias DFR, Ahad das Neves D, Ferreira da Silva L, Rodrigues Barretos EC, Tsuha Oshiro PE, Modafari Goday B, Lemos dos Santos JK, Kashima S, de Albuquerque CFC, Said RFDC, Rosewell A, Demarchi LHF, Croda J, Alcantara LCJ, Cavalheiro Maymone Gonçalves C. Dengue Fever Surveillance in Mato Grosso do Sul: Insights from Genomic Analysis and Implications for Public Health Strategies. Viruses 2023; 15:1790. [PMID: 37766197 PMCID: PMC10536684 DOI: 10.3390/v15091790] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/17/2023] [Revised: 08/17/2023] [Accepted: 08/21/2023] [Indexed: 09/29/2023] Open
Abstract
Since its discovery in early 1916, dengue fever, a common vector-borne illness in Brazil, has resulted in extensive urban outbreaks and poses a serious threat to the public's health. Understanding the dynamics of Dengue Virus (DENV) serotypes circulating in different regions of Brazil is essential for implementing effective disease control and prevention measures. In response to this urgent need, we conducted an on-site training program in genomic surveillance in collaboration with the Central Laboratory of Health and the Secretary of Health of the Mato Grosso do Sul state. This initiative resulted in the generation of 177 DENV genome sequences collected between May 2021 and May 2022, a period during which over 11,391 dengue fever cases were reported in the state. Through this approach, we were able to identify the co-circulation of two different dengue serotypes (DENV1 and DENV2) as well as the existence of diverse viral lineages within each genotype, suggesting that multiple introduction events of different viral strains occurred in the region. By integrating epidemiological data, our findings unveiled temporal fluctuations in the relative abundance of different serotypes throughout various epidemic seasons, highlighting the complex and changing dynamics of DENV transmission throughout time. These findings demonstrate the value of ongoing surveillance activities in tracking viral transmission patterns, monitoring viral evolution, and informing public health actions.
Collapse
Affiliation(s)
- Larissa Domingues Castilho de Arruda
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (L.D.C.d.A.); (L.d.M.A.M.); (D.F.R.F.); (D.A.d.N.); (L.F.d.S.); (E.C.R.B.); (P.E.T.O.); (B.M.G.); (J.K.L.d.S.)
- Universidade Federal do Estado do Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
| | - Marta Giovanetti
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil; (J.X.); (H.F.); (M.L.)
- Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di, 00128 Roma, Italy
| | - Vagner Fonseca
- Coordenação de Vigilância, Preparação e Resposta à Emergências e Desastres (PHE), Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasília 70312-970, DF, Brazil;
| | - Marina Castilhos Souza Umaki Zardin
- SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (S.A.); (M.T.M.); (L.H.F.D.)
| | - Gislene Garcia de Castro Lichs
- SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (S.A.); (M.T.M.); (L.H.F.D.)
| | - Silvia Asato
- SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (S.A.); (M.T.M.); (L.H.F.D.)
| | - Ana Olivia Pascoto Esposito
- SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (S.A.); (M.T.M.); (L.H.F.D.)
| | - Miriam Tokeshi Müller
- SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (S.A.); (M.T.M.); (L.H.F.D.)
| | - Joilson Xavier
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil; (J.X.); (H.F.); (M.L.)
| | - Hegger Fritsch
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil; (J.X.); (H.F.); (M.L.)
| | - Mauricio Lima
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil; (J.X.); (H.F.); (M.L.)
| | - Carla de Oliveira
- lnstituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, RJ, Brazil;
| | - Elaine Vieira Santos
- Fundação Hemocentro de Ribeirão Preto, Ribeirão Preto 14051-140, SP, Brazil (S.K.)
| | - Livia de Mello Almeida Maziero
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (L.D.C.d.A.); (L.d.M.A.M.); (D.F.R.F.); (D.A.d.N.); (L.F.d.S.); (E.C.R.B.); (P.E.T.O.); (B.M.G.); (J.K.L.d.S.)
- Universidade Federal do Estado do Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
| | - Danila Fernanda Rodrigues Frias
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (L.D.C.d.A.); (L.d.M.A.M.); (D.F.R.F.); (D.A.d.N.); (L.F.d.S.); (E.C.R.B.); (P.E.T.O.); (B.M.G.); (J.K.L.d.S.)
| | - Danielle Ahad das Neves
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (L.D.C.d.A.); (L.d.M.A.M.); (D.F.R.F.); (D.A.d.N.); (L.F.d.S.); (E.C.R.B.); (P.E.T.O.); (B.M.G.); (J.K.L.d.S.)
| | - Liliane Ferreira da Silva
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (L.D.C.d.A.); (L.d.M.A.M.); (D.F.R.F.); (D.A.d.N.); (L.F.d.S.); (E.C.R.B.); (P.E.T.O.); (B.M.G.); (J.K.L.d.S.)
- Universidade Federal do Estado do Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
| | - Ellen Caroline Rodrigues Barretos
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (L.D.C.d.A.); (L.d.M.A.M.); (D.F.R.F.); (D.A.d.N.); (L.F.d.S.); (E.C.R.B.); (P.E.T.O.); (B.M.G.); (J.K.L.d.S.)
| | - Paulo Eduardo Tsuha Oshiro
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (L.D.C.d.A.); (L.d.M.A.M.); (D.F.R.F.); (D.A.d.N.); (L.F.d.S.); (E.C.R.B.); (P.E.T.O.); (B.M.G.); (J.K.L.d.S.)
| | - Bianca Modafari Goday
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (L.D.C.d.A.); (L.d.M.A.M.); (D.F.R.F.); (D.A.d.N.); (L.F.d.S.); (E.C.R.B.); (P.E.T.O.); (B.M.G.); (J.K.L.d.S.)
| | - Jéssica Klener Lemos dos Santos
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (L.D.C.d.A.); (L.d.M.A.M.); (D.F.R.F.); (D.A.d.N.); (L.F.d.S.); (E.C.R.B.); (P.E.T.O.); (B.M.G.); (J.K.L.d.S.)
| | - Simone Kashima
- Fundação Hemocentro de Ribeirão Preto, Ribeirão Preto 14051-140, SP, Brazil (S.K.)
| | - Carlos F. C. de Albuquerque
- Organização Pan-Americana da Saúde, Organização Mundial da Saúde, Brasília 70312-970, DF, Brazil; (C.F.C.d.A.); (R.F.d.C.S.); (A.R.)
| | - Rodrigo Fabiano do Carmo Said
- Organização Pan-Americana da Saúde, Organização Mundial da Saúde, Brasília 70312-970, DF, Brazil; (C.F.C.d.A.); (R.F.d.C.S.); (A.R.)
| | - Alexander Rosewell
- Organização Pan-Americana da Saúde, Organização Mundial da Saúde, Brasília 70312-970, DF, Brazil; (C.F.C.d.A.); (R.F.d.C.S.); (A.R.)
| | - Luiz Henrique Ferraz Demarchi
- SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (M.C.S.U.Z.); (G.G.d.C.L.); (S.A.); (M.T.M.); (L.H.F.D.)
| | - Julio Croda
- Fundação Oswaldo Cruz, Universidade Federal de Mato Grosso do Sul-UFMS, Campo Grande 79000-000, MS, Brazil;
| | | | - Crhistinne Cavalheiro Maymone Gonçalves
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 79031-350, MS, Brazil; (L.D.C.d.A.); (L.d.M.A.M.); (D.F.R.F.); (D.A.d.N.); (L.F.d.S.); (E.C.R.B.); (P.E.T.O.); (B.M.G.); (J.K.L.d.S.)
- Universidade Federal do Estado do Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
| |
Collapse
|
33
|
Hoffmann EDR, Balzan LDR, Inamine E, Pancotto LR, Gaboardi G, Cantarelli VV. Performance of Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) Targeting the RNA Polymerase Gene for the Direct Detection of SARS-CoV2 in Nasopharyngeal Swabs. Int J Mol Sci 2023; 24:13056. [PMID: 37685863 PMCID: PMC10487735 DOI: 10.3390/ijms241713056] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2023] [Revised: 08/08/2023] [Accepted: 08/10/2023] [Indexed: 09/10/2023] Open
Abstract
In 2020, a global pandemic caused by SARS-CoV-2 was declared. Different institutes proposed diagnostic molecular methods to detect the virus in clinical samples. This study aims to validate and standardize the use of a loop-mediated isothermal amplification (LAMP)-based methodology targeting the viral RP gene, as a faster and low-cost diagnostic method for SARS-CoV-2 infections. The results obtained with RT-LAMP (Reverse Transcriptase) were compared to the results of real-time polymerase chain reaction (RT-PCR) to assess its sensitivity and specificity. In total, 115 samples (nasopharyngeal samples) were used for detecting SARS-CoV-2 by RT-LAMP, with 43 positives and 72 negatives. The study showed a positive predictive value (PPV) of 90.7% and a negative predictive value (VPN) of 100%. The LAMP assay also demonstrated a high sensitivity of 90.7% and a specificity of 100% (confidence interval 77.9-97.4%) when using the lower detection limit of 40 copies/µL. The RT-LAMP described here has the potential to detect even the new variants of SARS-CoV-2, suggesting that it may not be significantly affected by gene mutations. The RT-LAMP targeting the RP viral region is faster and less expensive than other molecular approaches, making it an alternative for developing countries.
Collapse
Affiliation(s)
- Elias da Rosa Hoffmann
- Basic Health Sciences Department, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre 90050-170, Brazil;
- Bom Pastor Laboratory, Molecular Biology Department, Igrejinha 95650-000, Brazil
| | | | - Everton Inamine
- Central Laboratory, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre 90020-090, Brazil; (E.I.)
| | - Lisiane Rech Pancotto
- Central Laboratory, Santa Casa de Misericórdia de Porto Alegre, Porto Alegre 90020-090, Brazil; (E.I.)
| | - Guilherme Gaboardi
- Biomedical Sciences Department, Serra Gaúcha University Center (FSG), Caxias do Sul 95020-472, Brazil
| | - Vlademir Vicente Cantarelli
- Basic Health Sciences Department, Federal University of Health Sciences of Porto Alegre (UFCSPA), Porto Alegre 90050-170, Brazil;
| |
Collapse
|
34
|
Giovanetti M, Branda F, Cella E, Scarpa F, Bazzani L, Ciccozzi A, Slavov SN, Benvenuto D, Sanna D, Casu M, Santos LA, Lai A, Zehender G, Caccuri F, Ianni A, Caruso A, Maroutti A, Pascarella S, Borsetti A, Ciccozzi M. Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2. J Med Virol 2023; 95:e29012. [PMID: 37548148 DOI: 10.1002/jmv.29012] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2023] [Revised: 07/12/2023] [Accepted: 07/20/2023] [Indexed: 08/08/2023]
Abstract
This comprehensive review focuses on the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its impact as the cause of the COVID-19 pandemic. Its objective is to provide a cohesive overview of the epidemic history and evolutionary aspects of the virus, with a particular emphasis on its emergence, global spread, and implications for public health. The review delves into the timelines and key milestones of SARS-CoV-2's epidemiological progression, shedding light on the challenges encountered during early containment efforts and subsequent waves of transmission. Understanding the evolutionary dynamics of the virus is crucial in monitoring its potential for adaptation and future outbreaks. Genetic characterization of SARS-CoV-2 is discussed, with a focus on the emergence of new variants and their implications for transmissibility, severity, and immune evasion. The review highlights the important role of genomic surveillance in tracking viral mutations linked to establishing public health interventions. By analyzing the origins, global spread, and genetic evolution of SARS-CoV-2, valuable insights can be gained for the development of effective control measures, improvement of pandemic preparedness, and addressing future emerging infectious diseases of international concern.
Collapse
Affiliation(s)
- Marta Giovanetti
- Instituto Rene Rachou Fundação Oswaldo Cruz, Belo Horizonte, Minas Gerais, Brazil
- Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Italy, Rome, Italy
| | - Francesco Branda
- Department of Computer Science, Modeling, Electronics and Systems Engineering (DIMES), University of Calabria, Rende, Italy
| | - Eleonora Cella
- Burnett School of Biomedical Sciences, University of Central Florida, Orlando, Florida, USA
| | - Fabio Scarpa
- Department of Biomedical Sciences, University of Sassari, Sassari, Italy
| | - Liliana Bazzani
- Sciences and Technologies for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Italy, Rome, Italy
| | - Alessandra Ciccozzi
- Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, Rome, Italy
| | - Svetoslav Nanev Slavov
- Butantan Institute, São Paulo, Brazil
- Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - Domenico Benvenuto
- Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, Rome, Italy
| | - Daria Sanna
- Department of Biomedical Sciences, University of Sassari, Sassari, Italy
| | - Marco Casu
- Department of Veterinary Medicine, University of Sassari, Sassari, Italy
| | - Luciane Amorim Santos
- Escola Bahiana de Medicina e Saúde Pública, Salvador, Bahia, Brazil
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil
- Programa de Pós-graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Praça Ramos de Queirós, s/n, Largo do Terreiro de Jesus, Salvador, Bahia, Brazil
| | - Alessia Lai
- Department of Biomedical and Clinical Sciences, L. Sacco Hospital, University of Milan, Milan, Italy
| | - Giangluglielmo Zehender
- Department of Biomedical and Clinical Sciences, L. Sacco Hospital, University of Milan, Milan, Italy
| | - Francesca Caccuri
- Section of Microbiology Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
| | - Andrea Ianni
- M.G. Vannini Hospital IFSC Rome, Research Unit in Hygiene UCBM Rome, Rome, Italy
| | - Arnaldo Caruso
- Section of Microbiology Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy
| | | | - Stefano Pascarella
- Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, Rome, Italy
| | | | - Massimo Ciccozzi
- Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, Rome, Italy
| |
Collapse
|
35
|
de Mello Almeida Maziero L, Giovanetti M, Fonseca V, Zardin MCSU, de Castro Lichs GG, de Rezende Romera GR, Tsuha DH, Frias DFR, Escandolhero VC, Demarchi LH, Domingues Castilho L, Barbosa KF, Tebet DGM, Xavier J, Fritsch H, Lima M, de Oliveira C, Santos EV, Kashima S, Said RFDC, Rosewell A, Croda J, Alcantara LCJ, Cavalheiro Maymone Gonçalves C. Unveiling the Impact of the Omicron Variant: Insights from Genomic Surveillance in Mato Grosso do Sul, Midwest Brazil. Viruses 2023; 15:1604. [PMID: 37515290 PMCID: PMC10386548 DOI: 10.3390/v15071604] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/03/2023] [Revised: 07/15/2023] [Accepted: 07/20/2023] [Indexed: 07/30/2023] Open
Abstract
Genomic surveillance has emerged as a crucial tool in monitoring and understanding the dynamics of viral variants during the COVID-19 pandemic. In the Midwest region of Brazil, Mato Grosso do Sul has faced a significant burden from the SARS-CoV-2 epidemic, with a total of 613,000 confirmed cases as of June 2023. In collaboration with the Central Public Health Laboratory in the capital city of Campo Grande, we conducted a portable whole-genome sequencing and phylodynamic analysis to investigate the circulation of the Omicron variant in the region. The study aimed to uncover the genomic landscape and provide valuable insights into the prevalence and transmission patterns of this highly transmissible variant. Our findings revealed an increase in the number of cases within the region during 2022, followed by a gradual decline as a result of the successful impact of the vaccination program together with the capacity of this unpredictable and very transmissible variant to quickly affect the proportion of susceptible population. Genomic data indicated multiple introduction events, suggesting that human mobility played a differential role in the variant's dispersion dynamics throughout the state. These findings emphasize the significance of implementing public health interventions to mitigate further spread and highlight the powerful role of genomic monitoring in promptly tracking and uncovering the circulation of viral strains. Together those results underscore the importance of proactive surveillance, rapid genomic sequencing, and data sharing to facilitate timely public health responses.
Collapse
Affiliation(s)
- Lívia de Mello Almeida Maziero
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil
- Universidade Federal de EMato Grosso do Sul, Campo Grande 79070-900, Brazil
| | - Marta Giovanetti
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Preto 30190-009, Brazil
- Sciences and Technologies for Sustainable Development and One Health, University of Campus Bio-Medico of Rome, 00128 Rome, Italy
| | - Vagner Fonseca
- Coordenação de Vigilância, Preparação e Resposta à Emergências e Desastres (PHE), Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasília 25045-002, Brazil
| | | | | | | | | | | | | | - Luiz Henrique Demarchi
- SES-MS-Laboratório Central de Saúde Pública de Mato Grosso do Sul, Campo Grande 79080-320, Brazil
| | - Larissa Domingues Castilho
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil
- Universidade Federal de EMato Grosso do Sul, Campo Grande 79070-900, Brazil
| | - Karine Ferreira Barbosa
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil
- Universidade Federal de EMato Grosso do Sul, Campo Grande 79070-900, Brazil
| | - Danielle Galindo Martins Tebet
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil
- Universidade Federal de EMato Grosso do Sul, Campo Grande 79070-900, Brazil
| | - Joilson Xavier
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Preto 30190-009, Brazil
| | - Hegger Fritsch
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Preto 30190-009, Brazil
| | - Mauricio Lima
- Instituto Rene Rachou, Fundação Oswaldo Cruz, Preto 30190-009, Brazil
| | - Carla de Oliveira
- lnstituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro 21040-900, Brazil
| | | | - Simone Kashima
- Fundação Hemocentro de Ribeirão Preto, Rio de Janeiro 14015-160, Brazil
| | | | - Alexander Rosewell
- Organização Pan-Americana da Saúde/Organização Mundial da Saúde (OPAS/OMS), Brasilia 25045-002, Brazil
| | - Julio Croda
- Fundação Oswaldo Cruz, Universidade Federal de Mato Grosso do Sul-UFMS, Campo Grande 79081-746, Brazil
| | | | - Crhistinne Cavalheiro Maymone Gonçalves
- Secretaria de Estado de Saúde de Mato Grosso do Sul, Campo Grande 9031-350, Brazil
- Universidade Federal de EMato Grosso do Sul, Campo Grande 79070-900, Brazil
| |
Collapse
|
36
|
da Silva MF, Dos Santos UR, Ferreira FB, Albuquerque GR, Mariano APM, Fehlberg HF, Santos de Santana ÍT, Dos Santos PR, Santos LC, Silva de Jesus LL, Piton KA, Costa BS, Gomes BSM, Porto VM, Oliveira EDS, Oliveira CL, Fontana R, Maciel BM, Silva MDM, Marin LJ, Gadelha SR. SARS-CoV-2 Infection in Cities from the Southern Region of Bahia State, Brazil: Analysis of Variables Associated in Both Individual and Community Level. Viruses 2023; 15:1583. [PMID: 37515269 PMCID: PMC10383252 DOI: 10.3390/v15071583] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/04/2023] [Revised: 07/15/2023] [Accepted: 07/17/2023] [Indexed: 07/30/2023] Open
Abstract
The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), challenged public health systems worldwide. Individuals in low-income countries/regions are still at individual and community risk concerning inequality, sanitation, and economic conditions. Besides, during the pandemic, the transmission in municipalities and communities in the countryside and less developed regions kept viral spread and required structured and strengthened clinical and laboratory surveillance. Here, we present an observational, analytic, cross-sectional study conducted using secondary data from the Laboratório de Farmacogenômica e Epidemiologia Molecular (LAFEM)-Universidade Estadual de Santa Cruz (UESC), to evaluate individual and community factors associated to SARS-CoV-2 infection in outpatients from different cities from Southern Region of Bahia State, in Brazil. The data were collected between June 2021 and May 2022. The SARS-CoV-2 positivity by RT-qPCR was correlated with low socio-economic indicators, including the Human development index (HDIc) and Average worker salary (AWSc). Besides, in general, females were less likely to test positive for SARS-CoV-2 (OR = 0.752; CI 95% 0.663-0.853; p < 0.0001), while brown individuals had more positivity for infection (p < 0.0001). In addition, those who had clinical symptoms were more likely to test positive for SARS-CoV-2 (OR = 6.000; CI 95% 4.932-7.299; p < 0.0001). Although dry cough, headache, and fever were the most frequent, loss of taste (OR = 5.574; CI 95% 4.334-7.186) and loss of smell (OR = 6.327; CI 95% 4.899-8.144) presented higher odds ratio to be positive to SARS-CoV-2 by RT-qPCR. Nonetheless, the distribution of these characteristics was not homogenous among the different cities, especially for age and gender. The dynamic of SARS-CoV-2 positivity differed between cities and the total population and reinforces the hypothesis that control strategies for prevention needed to be developed based on both individual and community risk levels to mitigate harm to individuals and the health system.
Collapse
Affiliation(s)
- Murillo Ferreira da Silva
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Pós-Graduação em Ciências da Saúde, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | | | - Fabrício Barbosa Ferreira
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Laboratório de Imunobiologia, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - George Rego Albuquerque
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Programa de Pós-Graduação em Ciência Animal, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Ana Paula Melo Mariano
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Hllytchaikra Ferraz Fehlberg
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Programa de Pós-Graduação em Ciência Animal, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | | | - Pérola Rodrigues Dos Santos
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Pós-Graduação em Ciências da Saúde, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Luciano Cardoso Santos
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Programa de Pós-Graduação em Ciência Animal, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Laine Lopes Silva de Jesus
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Karoline Almeida Piton
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Beatriz Santos Costa
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Beatriz Sena Moreira Gomes
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Vinicius Moreira Porto
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Emanuelly da Silva Oliveira
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Cibele Luz Oliveira
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Renato Fontana
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Bianca Mendes Maciel
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Mylene de Melo Silva
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Lauro Juliano Marin
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Departamento de Ciências da Saúde, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| | - Sandra Rocha Gadelha
- Laboratório de Farmacogenômica e Epidemiologia Molecular, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Pós-Graduação em Ciências da Saúde, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
- Departamento de Ciências Biológicas, Universidade Estadual de Santa Cruz, Ilhéus 45662-900, Brazil
| |
Collapse
|
37
|
Messina NL, Sperotto MG, Puga MAM, da Silva PV, de Oliveira RD, Moore CL, Pittet LF, Jamieson T, Dalcolmo M, dos Santos G, Jardim B, Lacerda MVG, Curtis N, Croda J. Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination. Front Immunol 2023; 14:1172851. [PMID: 37465688 PMCID: PMC10352084 DOI: 10.3389/fimmu.2023.1172851] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2023] [Accepted: 06/12/2023] [Indexed: 07/20/2023] Open
Abstract
Multiple factors, including vaccine platform and prior vaccinations, influence vaccine responses. We compared antibody responses to CoronaVac (Sinovac) and ChAdOx1-S (AstraZeneca-Oxford) vaccination in 874 healthcare workers in Brazil. As participants were randomised to BCG vaccination or placebo in the preceding 0-6 months as part of the BCG vaccination to reduce the impact of COVID-19 in healthcare workers (BRACE) trial, we also investigated the influence of recent BCG vaccination on antibody responses to these COVID-19 vaccines. Twenty-eight days after the second dose of each vaccine, ChAdOx1-S induced a stronger anti-spike IgG response than CoronaVac vaccination. Recent BCG vaccination did not impact IgG antibody responses to ChAdOx1-S or CoronaVac.
Collapse
Affiliation(s)
- Nicole L. Messina
- Infectious Diseases Group, Infection and Immunity Theme, Murdoch Children’s Research Institute, Parkville, VIC, Australia
- Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia
| | - Mariana G. Sperotto
- School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
- Oswaldo Cruz Foundation Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Marco A. M. Puga
- School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
- Oswaldo Cruz Foundation Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Patricia V. da Silva
- School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
- Oswaldo Cruz Foundation Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
| | - Roberto D. de Oliveira
- State University of Mato Grosso do Sul, Dourados-Mato Grosso do Sul, Brazil
- Federal University of Grande Dourados, Dourados, Brazil
| | - Cecilia L. Moore
- Clinical Epidemiology and Biostatistics Unit, Murdoch Children’s Research Institute, Parkville, VIC, Australia
| | - Laure F. Pittet
- Infectious Diseases Group, Infection and Immunity Theme, Murdoch Children’s Research Institute, Parkville, VIC, Australia
- Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia
- Infectious Diseases, The Royal Children’s Hospital Melbourne, Parkville, VIC, Australia
| | - Tenaya Jamieson
- Infectious Diseases Group, Infection and Immunity Theme, Murdoch Children’s Research Institute, Parkville, VIC, Australia
| | - Margareth Dalcolmo
- Helio Fraga Reference Center, Oswaldo Cruz Foundation Ministry of Health, Rio de Janeiro, Rio de Janeiro, Brazil
- Pontifical Catholic University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil
| | - Glauce dos Santos
- National School of Public Health, Oswaldo Cruz Foundation, Rio de Janeiro, Rio de Janeiro, Brazil
| | - Bruno Jardim
- Institute of Clinical Research Carlos Borborema, Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Amazonas, Brazil
| | - Marcus V. G. Lacerda
- Institute of Clinical Research Carlos Borborema, Fundação de Medicina Tropical Doutor Heitor Vieira Dourado, Manaus, Amazonas, Brazil
| | - Nigel Curtis
- Infectious Diseases Group, Infection and Immunity Theme, Murdoch Children’s Research Institute, Parkville, VIC, Australia
- Department of Paediatrics, The University of Melbourne, Parkville, VIC, Australia
- Infectious Diseases, The Royal Children’s Hospital Melbourne, Parkville, VIC, Australia
| | - Julio Croda
- School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
- Oswaldo Cruz Foundation Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil
- Yale School of Public Health, New Haven, CT, United States
| |
Collapse
|
38
|
Justo Arevalo S, Uribe Calampa CS, Jimenez Silva C, Quiñones Aguilar M, Bouckaert R, Rebello Pinho JR. Phylodynamic of SARS-CoV-2 during the second wave of COVID-19 in Peru. Nat Commun 2023; 14:3557. [PMID: 37322028 PMCID: PMC10272135 DOI: 10.1038/s41467-023-39216-8] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Accepted: 06/02/2023] [Indexed: 06/17/2023] Open
Abstract
At over 0.6% of the population, Peru has one of the highest SARS-CoV-2 mortality rate in the world. Much effort to sequence genomes has been done in this country since mid-2020. However, an adequate analysis of the dynamics of the variants of concern and interest (VOCIs) is missing. We investigated the dynamics of the COVID-19 pandemic in Peru with a focus on the second wave, which had the greatest case fatality rate. The second wave in Peru was dominated by Lambda and Gamma. Analysis of the origin of Lambda shows that it most likely emerged in Peru before the second wave (June-November, 2020). After its emergence it reached Argentina and Chile from Peru where it was locally transmitted. During the second wave in Peru, we identify the coexistence of two Lambda and three Gamma sublineages. Lambda sublineages emerged in the center of Peru whereas the Gamma sublineages more likely originated in the north-east and mid-east. Importantly, it is observed that the center of Peru played a prominent role in transmitting SARS-CoV-2 to other regions within Peru.
Collapse
Affiliation(s)
- Santiago Justo Arevalo
- Facultad de Ciencias Biológicas, Universidad Ricardo Palma, Lima, Peru.
- Laboratório Clínico do Hospital Israelita Albert Einstein, São Paulo, Brasil.
- Departamento de Bioquímica, Instituto de Química, Universidade de São Paulo, São Paulo, Brasil.
| | | | | | | | - Remco Bouckaert
- School of Computer Science, University of Auckland, Auckland, New Zealand
| | - Joao Renato Rebello Pinho
- Laboratório Clínico do Hospital Israelita Albert Einstein, São Paulo, Brasil
- LIM03/07, Department of Gastroenterology and Pathology, University of São Paulo School of Medicine, São Paulo, Brazil
| |
Collapse
|
39
|
Cribari-Neto F. A beta regression analysis of COVID-19 mortality in Brazil. Infect Dis Model 2023; 8:309-317. [PMID: 36945696 PMCID: PMC9988698 DOI: 10.1016/j.idm.2023.02.005] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/20/2023] [Revised: 02/26/2023] [Accepted: 02/26/2023] [Indexed: 03/09/2023] Open
Abstract
Brazil was one of the countries most impacted by the COVID-19 pandemic, with a cumulative total of nearly 700,000 deaths by early 2023. The country's federative units were unevenly affected by the pandemic and adopted mitigation measures of different scopes and intensity. There was intense conflict between the federal government and state governments over the relevance and extent of such measures. We build a simple regression model with good predictive power on state COVID-19 mortality rates in Brazil. Our results reveal that the federative units' urbanization rate and per capita income are important for determining their mean mortality rate and that the number of physicians per 100,000 inhabitants is important for modeling the mortality rate precision. Based on the fitted model, we obtain approximations for the levels of administrative efficiency of local governments in dealing with the pandemic.
Collapse
Affiliation(s)
- Francisco Cribari-Neto
- Department of Statistics, Federal University of Pernambuco, Recife, PE, 50670-901, Brazil
| |
Collapse
|
40
|
Kurtz P, Bastos LSL, Ranzani OT, Soares M, Zampieri F, Hamacher S, Salluh J, Bozza FA. Variants of concern and clinical outcomes in critically ill COVID-19 patients. Intensive Care Med 2023; 49:697-699. [PMID: 37067557 PMCID: PMC10108805 DOI: 10.1007/s00134-023-07039-2] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/14/2023] [Indexed: 04/18/2023]
|
41
|
Bazzani L, Imperia E, Scarpa F, Sanna D, Casu M, Borsetti A, Pascarella S, Petrosillo N, Cella E, Giovanetti M, Ciccozzi M. SARS-CoV CH.1.1 Variant: Genomic and Structural Insight. Infect Dis Rep 2023; 15:292-298. [PMID: 37367188 DOI: 10.3390/idr15030029] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/19/2023] [Revised: 05/16/2023] [Accepted: 05/17/2023] [Indexed: 06/28/2023] Open
Abstract
In early February 2023, the Omicron subvariant XBB.1.5, also known as "Kraken", accounted for more than 44% of new COVID-19 cases worldwide, whereas a relatively new Omicron subvariant named CH.1.1, deemed "Orthrus", accounted for less than 6% of new COVID-19 cases during the subsequent weeks. This emerging variant carries a mutation, L452R, previously observed in the highly pathogenic Delta and the highly transmissible BA.4 and BA.5 variants, necessitating a shift to active surveillance to assure adequate preparedness for likely future epidemic peaks. We provide a preliminary understanding of the global distribution of this emerging SARS-CoV-2 variant by combining genomic data with structural molecular modeling. In addition, we shield light on the number of specific point mutations in this lineage that may have functional significance, thereby increasing the risk of disease severity, vaccine resistance, and increased transmission. This variant shared about 73% of the mutations with Omicron-like strains. Our homology modeling analysis revealed that CH.1.1 may have a weakened interaction with ACE2 and that its electrostatic potential surface appears to be more positive than that of the reference ancestral virus. Finally, our phylogenetic analysis revealed that this likely-emerging variant was already cryptically circulating in European countries prior to its first detection, highlighting the importance of having access to whole genome sequences for detecting and controlling emerging viral strains.
Collapse
Affiliation(s)
- Liliana Bazzani
- Sciences and Technologies for Sustainable Development and One Health, University Campus Bio-Medico of Rome, 00128 Rome, Italy
| | - Elena Imperia
- Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, 00128 Rome, Italy
- Unit of Gastroenterology, Department of Medicine, University Campus Bio-Medico of Rome, 00128 Rome, Italy
| | - Fabio Scarpa
- Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy
| | - Daria Sanna
- Department of Biomedical Sciences, University of Sassari, 07100 Sassari, Italy
| | - Marco Casu
- Department of Veterinary Medicine, University of Sassari, 07100 Sassari, Italy
| | - Alessandra Borsetti
- National HIV/AIDS Research Center (CNAIDS), National Institute of Health, 00161 Rome, Italy
| | - Stefano Pascarella
- Department of Biochemical Sciences "A. Rossi Fanelli", Sapienza University of Rome, 00185 Rome, Italy
| | - Nicola Petrosillo
- Infection Prevention and Control-Infectious Disease Service, Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy
| | - Eleonora Cella
- Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32816, USA
| | - Marta Giovanetti
- Sciences and Technologies for Sustainable Development and One Health, University Campus Bio-Medico of Rome, 00128 Rome, Italy
- Instituto Rene Rachou Fundação Oswaldo Cruz, Belo Horizonte 30190-002, MG, Brazil
| | - Massimo Ciccozzi
- Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, 00128 Rome, Italy
| |
Collapse
|
42
|
Adu B, Bonney JH, Egyir B, Otchere ID, Asare P, Dennis FE, Bonney EY, Akuffo R, Asante IA, Obodai E, Kumordjie S, Appiah-Kubi J, Mohktar Q, Frempong HO, Asiedu-Bekoe F, Adusei-Poku MA, Aboagye JO, Agbodzi B, Yeboah C, Agbenyo SB, Uche PO, Attiku KO, Sekyere BT, Laryea D, Buabeng K, Lamptey H, Ghansah A, Yeboah-Manu D, Anang AK, Ampofo WK, Kyei GB, Odoom JK. SARS-CoV-2 Molecular Evolutionary Dynamics in the Greater Accra Region, Ghana. Emerg Infect Dis 2023; 29:862-865. [PMID: 36958011 PMCID: PMC10045712 DOI: 10.3201/eid2904.221410] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/25/2023] Open
Abstract
To assess dynamics of SARS-CoV-2 in Greater Accra Region, Ghana, we analyzed SARS-CoV-2 genomic sequences from persons in the community and returning from international travel. The Accra Metropolitan District was a major origin of virus spread to other districts and should be a primary focus for interventions against future infectious disease outbreaks.
Collapse
Affiliation(s)
| | | | - Beverly Egyir
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Isaac Darko Otchere
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Prince Asare
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Francis E. Dennis
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Evelyn Yayra Bonney
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Richard Akuffo
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Ivy A. Asante
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Evangeline Obodai
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Selassie Kumordjie
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Joyce Appiah-Kubi
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Quaneeta Mohktar
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Hilda Opoku Frempong
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Franklin Asiedu-Bekoe
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Mildred A. Adusei-Poku
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - James O. Aboagye
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Bright Agbodzi
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Clara Yeboah
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Seyram B. Agbenyo
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Peace O. Uche
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Keren O. Attiku
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Bernice Twenewaa Sekyere
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Dennis Laryea
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Kwame Buabeng
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Helena Lamptey
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Anita Ghansah
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Dorothy Yeboah-Manu
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - Abraham K. Anang
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - William K. Ampofo
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - George B. Kyei
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| | - John K. Odoom
- Noguchi Memorial Institute for Medical Research, University of Ghana College of Health Sciences, Legon, Ghana (B. Adu, J.H.K. Bonney, B. Egyir, I.D. Otchere, P. Asare, F.E. Dennis, E.Y. Bonney, R. Akuffo, I.A. Asante, E. Obodai, S. Kumordjie, J. Appiah-Kubi, Q. Mohktar, H. Opoku Frempong, J.O. Aboagye, B. Agbodzi, C. Yeboah, S.B. Agbenyo, P.O. Uche, K.O. Attiku, B. Twenewaa Sekyere, D. Laryea, K. Buabeng, H. Lamptey, A. Ghansah, D. Yeboah-Manu, A.K. Anang, W.K. Ampofo, G.B. Kyei, J.K. Odoom)
- Ghana Health Service, Accra, Ghana (F. Asiedu-Bekoe)
- University of Ghana Medical School, Accra (M.A. Adusei-Poku)
- University of Ghana Medical Centre, Legon (G.B. Kyei)
| |
Collapse
|
43
|
Lamarca AP, Souza UJBD, Moreira FRR, Almeida LGPD, Menezes MTD, Souza ABD, Ferreira ACDS, Gerber AL, Lima ABD, Guimarães APDC, Cavalcanti AC, Silva ABPE, Lima BI, Lobato C, Silva CGD, Mendonça CPTB, Queiroz DC, Zauli DAG, Menezes D, Possebon FS, Cardoso FDP, Malta FSV, Braga-Paz I, Silva JDP, Ferreira JGG, Galvão JD, Souza LMD, Ferreira L, Possuelo LG, Cavalcante LTDF, Alvim LB, Souza LFAD, Santos LCGDAE, Dias RC, Souza RB, Castro TRY, Valim ARDM, Campos FS, Araujo JP, Trindade PDA, Aguiar RS, Michael Delai R, Vasconcelos ATRD. The Omicron Lineages BA.1 and BA.2 ( Betacoronavirus SARS-CoV-2) Have Repeatedly Entered Brazil through a Single Dispersal Hub. Viruses 2023; 15:888. [PMID: 37112869 PMCID: PMC10146814 DOI: 10.3390/v15040888] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2023] [Revised: 03/20/2023] [Accepted: 03/27/2023] [Indexed: 04/03/2023] Open
Abstract
Brazil currently ranks second in absolute deaths by COVID-19, even though most of its population has completed the vaccination protocol. With the introduction of Omicron in late 2021, the number of COVID-19 cases soared once again in the country. We investigated in this work how lineages BA.1 and BA.2 entered and spread in the country by sequencing 2173 new SARS-CoV-2 genomes collected between October 2021 and April 2022 and analyzing them in addition to more than 18,000 publicly available sequences with phylodynamic methods. We registered that Omicron was present in Brazil as early as 16 November 2021 and by January 2022 was already more than 99% of samples. More importantly, we detected that Omicron has been mostly imported through the state of São Paulo, which in turn dispersed the lineages to other states and regions of Brazil. This knowledge can be used to implement more efficient non-pharmaceutical interventions against the introduction of new SARS-CoV variants focused on surveillance of airports and ground transportation.
Collapse
Affiliation(s)
- Alessandra P Lamarca
- Laboratório de Bioinformática, Laboratório Nacional de Computação Científica, Petrópolis 25651-075, Brazil
| | - Ueric José Borges de Souza
- Laboratório de Bioinformática e Biotecnologia, Universidade Federal do Tocantins, Campus de Gurupi, Palmas 77410-570, Brazil
| | - Filipe Romero Rebello Moreira
- Laboratório de Virologia Molecular, Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-901, Brazil
| | - Luiz G P de Almeida
- Laboratório de Bioinformática, Laboratório Nacional de Computação Científica, Petrópolis 25651-075, Brazil
| | - Mariane Talon de Menezes
- Laboratório de Virologia Molecular, Departamento de Genética, Instituto de Biologia, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21941-901, Brazil
| | | | | | - Alexandra L Gerber
- Laboratório de Bioinformática, Laboratório Nacional de Computação Científica, Petrópolis 25651-075, Brazil
| | - Aline B de Lima
- Departamento de Pesquisa & Desenvolvimento, Instituto Hermes Pardini, Belo Horizonte 30140-070, Brazil
| | - Ana Paula de C Guimarães
- Laboratório de Bioinformática, Laboratório Nacional de Computação Científica, Petrópolis 25651-075, Brazil
| | | | - Aryel B Paz E Silva
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Bruna Israel Lima
- Laboratório de Biologia Molecular, Parque Científico e Tecnológico Regional, Universidade de Santa Cruz do Sul, Santa Cruz do Sul 96815-900, Brazil
| | - Cirley Lobato
- Centro de Ciências de Saúde e do Desporto, Universidade Federal do Acre, Rio Branco 69920-900, Brazil
| | | | - Cristiane P T B Mendonça
- Departamento de Pesquisa & Desenvolvimento, Instituto Hermes Pardini, Belo Horizonte 30140-070, Brazil
| | - Daniel Costa Queiroz
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | | | - Diego Menezes
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Fábio Sossai Possebon
- Instituto de Biotecnologia, Universidade Estadual Paulista, Botucatu 18618-689, Brazil
| | | | | | - Isabela Braga-Paz
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Joice do Prado Silva
- Departamento de Pesquisa & Desenvolvimento, Instituto Hermes Pardini, Belo Horizonte 30140-070, Brazil
| | - Jorge Gomes Goulart Ferreira
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | | | | | - Leonardo Ferreira
- Centro de Medicina Tropical da Tríplice Fronteira, Foz do Iguaçu 85866-010, Brazil
| | - Lia Gonçalves Possuelo
- Departmento de Ciências da Vida, Universidade de Santa Cruz do Sul, Santa Cruz do Sul 96815-900, Brazil
| | | | - Luige B Alvim
- Departamento de Pesquisa & Desenvolvimento, Instituto Hermes Pardini, Belo Horizonte 30140-070, Brazil
| | - Luiz Fellype Alves de Souza
- Centro de Infectologia Charles Mérieux and Laboratório Rodolphe Mérieux, Hospital das Clínicas do Acre, Rio Branco 69920-223, Brazil
| | - Luiza C G de Araújo E Santos
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Rillery Calixto Dias
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Rutilene Barbosa Souza
- Centro de Infectologia Charles Mérieux and Laboratório Rodolphe Mérieux, Hospital das Clínicas do Acre, Rio Branco 69920-223, Brazil
| | - Thaís Regina Y Castro
- Laboratório de Biologia Molecular e Bioinformática Aplicadas a Microbiologia Clínica, Universidade Federal de Santa Maria, Santa Maria 97105-900, Brazil
| | | | - Fabrício Souza Campos
- Laboratório de Virologia, Departamento de Microbiologia, Imunologia e Parasitologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre 90010-150, Brazil
| | - João Pessoa Araujo
- Instituto de Biotecnologia, Universidade Estadual Paulista, Botucatu 18618-689, Brazil
| | - Priscila de Arruda Trindade
- Laboratório de Biologia Molecular e Bioinformática Aplicadas a Microbiologia Clínica, Universidade Federal de Santa Maria, Santa Maria 97105-900, Brazil
| | - Renato S Aguiar
- Departamento de Genética, Ecologia e Evolução, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Robson Michael Delai
- Centro de Medicina Tropical da Tríplice Fronteira, Foz do Iguaçu 85866-010, Brazil
| | | |
Collapse
|
44
|
Tosta S, Moreno K, Schuab G, Fonseca V, Segovia FMC, Kashima S, Elias MC, Sampaio SC, Ciccozzi M, Alcantara LCJ, Slavov SN, Lourenço J, Cella E, Giovanetti M. Global SARS-CoV-2 genomic surveillance: What we have learned (so far). INFECTION, GENETICS AND EVOLUTION : JOURNAL OF MOLECULAR EPIDEMIOLOGY AND EVOLUTIONARY GENETICS IN INFECTIOUS DISEASES 2023; 108:105405. [PMID: 36681102 PMCID: PMC9847326 DOI: 10.1016/j.meegid.2023.105405] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/13/2022] [Revised: 01/13/2023] [Accepted: 01/17/2023] [Indexed: 01/20/2023]
Abstract
The COVID-19 pandemic has brought significant challenges for genomic surveillance strategies in public health systems worldwide. During the past thirty-four months, many countries faced several epidemic waves of SARS-CoV-2 infections, driven mainly by the emergence and spread of novel variants. In that line, genomic surveillance has been a crucial toolkit to study the real-time SARS-CoV-2 evolution, for the assessment and optimization of novel diagnostic assays, and to improve the efficacy of existing vaccines. During the pandemic, the identification of emerging lineages carrying lineage-specific mutations (particularly those in the Receptor Binding domain) showed how these mutations might significantly impact viral transmissibility, protection from reinfection and vaccination. So far, an unprecedented number of SARS-CoV-2 viral genomes has been released in public databases (i.e., GISAID, and NCBI), achieving 14 million genome sequences available as of early-November 2022. In the present review, we summarise the global landscape of SARS-CoV-2 during the first thirty-four months of viral circulation and evolution. It demonstrates the urgency and importance of sustained investment in genomic surveillance strategies to timely identify the emergence of any potential viral pathogen or associated variants, which in turn is key to epidemic and pandemic preparedness.
Collapse
Affiliation(s)
- Stephane Tosta
- Interunit Postgraduate Program in Bioinformatics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Keldenn Moreno
- Interunit Postgraduate Program in Bioinformatics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
| | - Gabriel Schuab
- Federal University of Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil; Laboratório de Flavivirus, Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil
| | - Vagner Fonseca
- Organização Pan-Americana da Saúde/Organização Mundial da Saúde, Brasília, Distrito Federal, Brazil.
| | | | - Simone Kashima
- Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo,Brazil
| | | | | | - Massimo Ciccozzi
- Unit of Medical Statistics and Molecular Epidemiology, University Campus Bio-Medico of Rome, Italy
| | - Luiz Carlos Junior Alcantara
- Interunit Postgraduate Program in Bioinformatics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Laboratório de Flavivirus, Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil
| | - Svetoslav Nanev Slavov
- Blood Center of Ribeirão Preto, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, São Paulo,Brazil; Butantan Institute, São Paulo, Brazil
| | - José Lourenço
- BioISI (Biosystems and Integrative Sciences Institute), Faculdade de Ciências da Universidade de Lisboa, Lisboa,Portugal
| | - Eleonora Cella
- Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL 32827, USA.
| | - Marta Giovanetti
- Interunit Postgraduate Program in Bioinformatics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil; Laboratório de Flavivirus, Instituto Oswaldo Cruz, Rio de Janeiro, Rio de Janeiro, Brazil; Department of Science and Technology for Humans and the Environment, University of Campus Bio-Medico di Roma, Rome, Italy.
| |
Collapse
|
45
|
de Araújo JC, Madeira CL, Bressani T, Leal C, Leroy D, Machado EC, Fernandes LA, Espinosa MF, Freitas GTO, Leão T, Mota VT, Pereira AD, Perdigão C, Tröger F, Ayrimoraes S, de Melo MC, Laguardia F, Reis MTP, Mota C, Chernicharo CAL. Quantification of SARS-CoV-2 in wastewater samples from hospitals treating COVID-19 patients during the first wave of the pandemic in Brazil. THE SCIENCE OF THE TOTAL ENVIRONMENT 2023; 860:160498. [PMID: 36436622 PMCID: PMC9691275 DOI: 10.1016/j.scitotenv.2022.160498] [Citation(s) in RCA: 12] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 08/24/2022] [Revised: 11/20/2022] [Accepted: 11/21/2022] [Indexed: 06/04/2023]
Abstract
The COVID-19 pandemic has caused a global health crisis, and wastewater-based epidemiology (WBE) has emerged as an important tool to assist public health decision-making. Recent studies have shown that the SARS-CoV-2 RNA concentration in wastewater samples is a reliable indicator of the severity of the pandemic for large populations. However, few studies have established a strong correlation between the number of infected people and the viral concentration in wastewater due to variations in viral shedding over time, viral decay, infiltration, and inflow. Herein we present the relationship between the number of COVID-19-positive patients and the viral concentration in wastewater samples from three different hospitals (A, B, and C) in the city of Belo Horizonte, Minas Gerais, Brazil. A positive and strong correlation between wastewater SARS-CoV-2 concentration and the number of confirmed cases was observed for Hospital B for both regions of the N gene (R = 0.89 and 0.77 for N1 and N2, respectively), while samples from Hospitals A and C showed low and moderate correlations, respectively. Even though the effects of viral decay and infiltration were minimized in our study, the variability of viral shedding throughout the infection period and feces dilution due to water usage for different activities in the hospitals could have affected the viral concentrations. These effects were prominent in Hospital A, which had the smallest sewershed population size, and where no correlation between the number of defecations from COVID-19 patients and viral concentration in wastewater was observed. Although we could not determine trends in the number of infected patients through SARS-CoV-2 concentrations in hospitals' wastewater samples, our results suggest that wastewater monitoring can be efficient for the detection of infected individuals at a local level, complementing clinical data.
Collapse
Affiliation(s)
- Juliana Calábria de Araújo
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil.
| | - Camila L Madeira
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Thiago Bressani
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Cíntia Leal
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Deborah Leroy
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Elayne C Machado
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Luyara A Fernandes
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Maria Fernanda Espinosa
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Gabriel Tadeu O Freitas
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Thiago Leão
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Vera Tainá Mota
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Alyne Duarte Pereira
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | | | - Flávio Tröger
- National Agency for Water and Sanitation (ANA), Brazil
| | | | | | | | | | - César Mota
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| | - Carlos A L Chernicharo
- Department of Sanitary and Environmental Engineering (DESA), Federal University of Minas Gerais (UFMG), Brazil
| |
Collapse
|
46
|
de Menezes MT, Moreira FRR, Whittaker C, Santos FM, Queiroz DC, Geddes V, Fonseca PLC, de Jesus JG, Mendes-Oliveira F, Reis-Souza V, Santos B, Zauli DAG, de Lima AB, de Brito Mendonça C, Alvim LB, do Prado Silva J, Malta FSV, de Souza Ferreira AC, Faria NR, Sabino EC, Aguiar RS. Dynamics of Early Establishment of SARS-CoV-2 VOC Omicron Lineages in Minas Gerais, Brazil. Viruses 2023; 15:585. [PMID: 36851799 PMCID: PMC9962645 DOI: 10.3390/v15020585] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/27/2022] [Revised: 01/21/2023] [Accepted: 01/24/2023] [Indexed: 02/22/2023] Open
Abstract
Brazil is one of the nations most affected by Coronavirus disease 2019 (COVID-19). The introduction and establishment of new virus variants can be related to an increase in cases and fatalities. The emergence of Omicron, the most modified SARS-CoV-2 variant, caused alarm for the public health of Brazil. In this study, we examined the effects of the Omicron introduction in Minas Gerais (MG), the second-most populous state of Brazil. A total of 430 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) samples from November 2021 to June 2022 from Belo Horizonte (BH) city were sequenced. These newly sequenced genomes comprise 72% of all previously available SARS-CoV-2 genomes for the city. Evolutionary analysis of novel viral genomes reveals that a great diversity of Omicron sublineages have circulated in BH, a pattern in-keeping with observations across Brazil more generally. Bayesian phylogeographic reconstructions indicate that this diversity is a product of a large number of international and national importations. As observed previously, São Paulo state is shown as a significant hub for viral spread throughout the country, contributing to around 70% of all viral Omicron introductions detected in MG.
Collapse
Affiliation(s)
- Mariane Talon de Menezes
- Laboratory of Molecular Virology, Institute of Biology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-901, Brazil
| | - Filipe Romero Rebello Moreira
- Laboratory of Molecular Virology, Institute of Biology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-901, Brazil
- MRC Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2BX, UK
| | - Charles Whittaker
- MRC Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2BX, UK
| | - Franciele Martins Santos
- Laboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil
| | - Daniel Costa Queiroz
- Laboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil
| | - Victor Geddes
- Laboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil
| | - Paula Luize Camargos Fonseca
- Laboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil
| | - Jaqueline Góes de Jesus
- Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
- Department of Infectious and Parasitic Diseases, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
| | - Franciane Mendes-Oliveira
- Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
| | - Valquíria Reis-Souza
- Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
| | | | | | - Aline Brito de Lima
- Pardini Group, Research and Development Department, Belo Horizonte 31270, Brazil
| | | | - Luige Biciati Alvim
- Pardini Group, Research and Development Department, Belo Horizonte 31270, Brazil
| | - Joice do Prado Silva
- Pardini Group, Research and Development Department, Belo Horizonte 31270, Brazil
| | | | | | - Nuno R. Faria
- MRC Centre for Global Infectious Disease Analysis, Imperial College London, London SW7 2BX, UK
- Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
- Department of Zoology, University of Oxford, Oxford OX3 7BN, UK
| | - Ester Cerdeira Sabino
- Institute of Tropical Medicine, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
- Department of Infectious and Parasitic Diseases, Faculty of Medicine, University of São Paulo, São Paulo 04023, Brazil
| | - Renato Santana Aguiar
- Laboratory of Molecular Virology, Institute of Biology, Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro 21941-901, Brazil
- Laboratory of Integrative Biology, Department of Genetics, Ecology and Evolution, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte 31270, Brazil
- D’OR Institute of Research and Teaching, Rio de Janeiro 21941-901, Brazil
| |
Collapse
|
47
|
Assato PA, Clemente LG, Giovanetti M, Ribeiro G, Lima ARJ, Palmieri M, de Moraes LN, Kashima S, Fukumasu H, Nogueira ML, Alcantara LCJ, Nicolodelli AL, Martins AJ, Petry B, Banho CA, Dos Santos Barros CR, Moncau-Gadbem CT, Moretti DB, De La Roque DGL, Marqueze EC, Mattos EC, Silva FEVD, Da Costa FADS, Cacherik G, De Souza Todao Bernardino J, Lesbon JCC, Sacchetto L, De Lima LPO, Caldeira LAV, Martininghi M, Moraes MM, Poleti MD, Cattony Neto PDQ, Cassano RDLRC, Brassaloti RA, Slavov SN, Viala VL, Coutinho LL, Grotto RMT, Neto RM, Covas DT, Sampaio SC, Elias MC, Souza-Neto JA. Retrospective Insights of the COVID-19 Epidemic in the Major Latin American City, São Paulo, Southeastern Brazil. Viruses 2023; 15:327. [PMID: 36851541 PMCID: PMC9965911 DOI: 10.3390/v15020327] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2022] [Revised: 01/11/2023] [Accepted: 01/12/2023] [Indexed: 01/26/2023] Open
Abstract
São Paulo is the financial center of Brazil, with a population of over 12 million, that receives travelers from all over the world for business and tourism. It was the first city in Brazil to report a case of COVID-19 that rapidly spread across the city despite the implementation of the restriction measures. Despite many reports, much is still unknown regarding the genomic diversity and transmission dynamics of this virus in the city of São Paulo. Thus, in this study, we provide a retrospective overview of the COVID-19 epidemic in São Paulo City, Southeastern, Brazil, by generating a total of 9995 near-complete genome sequences from all the city's different macro-regions (North, West, Central, East, South, and Southeast). Our analysis revealed that multiple independent introduction events of different variants (mainly Gamma, Delta, and Omicron) occurred throughout time. Additionally, our estimates of viral movement within the different macro-regions further suggested that the East and the Southeast regions were the largest contributors to the Gamma and Delta viral exchanges to other regions. Meanwhile, the North region had a higher contribution to the dispersion of the Omicron variant. Together, our results reinforce the importance of increasing SARS-CoV-2 genomic monitoring within the city and the country to track the real-time evolution of the virus and to detect earlier any eventual emergency of new variants of concern that could undermine the fight against COVID-19 in Brazil and worldwide.
Collapse
Affiliation(s)
- Patricia Akemi Assato
- School of Agricultural Sciences, São Paulo State University (UNESP), Botucatu 18610-034, Brazil
| | - Luan Gaspar Clemente
- Centro de Genômica Funcional da ESALQ, University of São Paulo, Piracicaba 13418-900, Brazil
| | - Marta Giovanetti
- Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-360, Brazil
- Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
- Department of Science and Technology for Humans and the Environment, University of Campus Bio-Medico di Roma, 00128 Rome, Italy
| | | | | | - Melissa Palmieri
- Health Surveillance Coordination, Sao Paulo Municipal Health Department—Coordenadoria de Vigilância em Saúde—Secretaria Municipal de São Paulo, Sao Paulo 05579-000, Brazil
| | | | - Simone Kashima
- Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, Brazil
| | - Heidge Fukumasu
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of Sao Paulo, Pirassununga 13635-900, Brazil
| | | | - Luiz Carlos Junior Alcantara
- Instituto Oswaldo Cruz, FIOCRUZ, Rio de Janeiro 21040-360, Brazil
- Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil
| | - Aline Lais Nicolodelli
- Primary Care Coordination/Sao Paulo Municipal Health Department—Coordenadoria de Atenção Básica—Secretaria Municipal de São Paulo, Sao Paulo 05579-000, Brazil
| | | | - Bruna Petry
- Centro de Genômica Funcional da ESALQ, University of São Paulo, Piracicaba 13418-900, Brazil
| | - Cecilia Artico Banho
- Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto 15090-000, Brazil
| | | | | | | | - Debora Glenda Lima De La Roque
- Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, Brazil
| | | | - Elisangela Chicaroni Mattos
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of Sao Paulo, Pirassununga 13635-900, Brazil
| | - Fabiana Erica Vilanova Da Silva
- Primary Care Coordination/Sao Paulo Municipal Health Department—Coordenadoria de Atenção Básica—Secretaria Municipal de São Paulo, Sao Paulo 05579-000, Brazil
| | | | - Giselle Cacherik
- Primary Care Coordination/Sao Paulo Municipal Health Department—Coordenadoria de Atenção Básica—Secretaria Municipal de São Paulo, Sao Paulo 05579-000, Brazil
| | | | - Jessika Cristina Chagas Lesbon
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of Sao Paulo, Pirassununga 13635-900, Brazil
| | - Lívia Sacchetto
- Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto 15090-000, Brazil
| | | | - Luiz Artur Vieira Caldeira
- Health Surveillance Coordination, Sao Paulo Municipal Health Department—Coordenadoria de Vigilância em Saúde—Secretaria Municipal de São Paulo, Sao Paulo 05579-000, Brazil
| | - Maiara Martininghi
- Health Surveillance Coordination, Sao Paulo Municipal Health Department—Coordenadoria de Vigilância em Saúde—Secretaria Municipal de São Paulo, Sao Paulo 05579-000, Brazil
| | - Marília Mazzi Moraes
- Faculdade de Medicina de São José do Rio Preto (FAMERP), São José do Rio Preto 15090-000, Brazil
| | - Mirele Daiana Poleti
- Department of Veterinary Medicine, School of Animal Science and Food Engineering, University of Sao Paulo, Pirassununga 13635-900, Brazil
| | | | | | | | - Svetoslav Nanev Slavov
- Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, Brazil
| | | | - Luiz Lehmann Coutinho
- Centro de Genômica Funcional da ESALQ, University of São Paulo, Piracicaba 13418-900, Brazil
| | - Rejane Maria Tommasini Grotto
- School of Agricultural Sciences, São Paulo State University (UNESP), Botucatu 18610-034, Brazil
- Genomic Surveillance Network, São Paulo State University (UNESP), Sao Paulo 01049-010, Brazil
| | | | - Dimas Tadeu Covas
- Butantan Institute, Sao Paulo 05508-040, Brazil
- Ribeirão Preto Medical School, Blood Center of Ribeirão Preto, University of São Paulo, Ribeirão Preto 14051-140, Brazil
| | | | | | - Jayme A. Souza-Neto
- School of Agricultural Sciences, São Paulo State University (UNESP), Botucatu 18610-034, Brazil
- Genomic Surveillance Network, São Paulo State University (UNESP), Sao Paulo 01049-010, Brazil
| |
Collapse
|
48
|
SARS-CoV-2 Genomic Surveillance in Brazil: A Systematic Review with Scientometric Analysis. Viruses 2022; 14:v14122715. [PMID: 36560720 PMCID: PMC9784312 DOI: 10.3390/v14122715] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2022] [Revised: 11/30/2022] [Accepted: 12/02/2022] [Indexed: 12/09/2022] Open
Abstract
Several studies have monitored the SARS-CoV-2 variants in Brazil throughout the pandemic. Here, we systematically reviewed and conducted a scientometric analysis of the SARS-CoV-2 genomic surveillance studies using Brazilian samples. A Pubmed database search on October 2022 returned 492 articles, of which 106 were included. Ninety-six different strains were reported, with variant of concern (VOC) gamma (n = 35,398), VOC delta (n = 15,780), and the variant of interest zeta (n = 1983) being the most common. The top three states with the most samples in the published articles were São Paulo, Rio de Janeiro, and Minas Gerais. Whereas the first year of the pandemic presented primary circulation of B.1.1.28 and B.1.1.33 variants, consecutive replacements were observed between them and VOI zeta, VOC gamma, VOC delta, and VOC omicron. VOI mu, VOI lambda, VOC alpha, and VOC beta were also detected but failed to reach significant circulation. Co-infection, re-infection, and vaccine breakthrough reports were found. Article co-citation differed from the co-authorship structure. Despite the limitations, we expect to give an overview of Brazil's genomic surveillance studies and contribute to future research execution.
Collapse
|
49
|
Prosperi M, Rife B, Marini S, Salemi M. Transmission cluster characteristics of global, regional, and lineage-specific SARS-CoV-2 phylogenies. IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE WORKSHOPS. IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE 2022; 2022:2940-2944. [PMID: 36780250 PMCID: PMC9912475 DOI: 10.1109/bibm55620.2022.9995364] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
The SARS-CoV-2 pandemic has been presenting in periodic waves and multiple variants, of which some dominated over time with increased transmissibility. SARS-CoV-2 is still adapting in the human population, thus it is crucial to understand its evolutionary patterns and dynamics ahead of time. In this work, we analyzed transmission clusters and topology of SARS-CoV-2 phylogenies at the global, regional (North America) and clade-specific (Delta and Omicron) epidemic scales. We used the Nextstrain's nCov open global all-time phylogeny (September 2022, 2,698 strains, 2,243 for North America, 499 for Delta21A, and 543 for Omicron20M), with Nextstrain's clade annotation and Pango lineages. Transmission clusters were identified using Phylopart, DYNAMITE, and several tree imbalance measures were calculated, including staircase-ness, Sackin and Colless index. We found that the phylogenetic clustering profiles of the global epidemic have highest diversification at a distance threshold of 3% (divergence of 10, where the tree sampled median is 49). Phylopart and DYNAMITE clusters moderately-to-highly agree with the Pango nomenclature and the Nextstrain's clade. At the regional and clade-specific scale, transmission clustering profiles tend to flatten and similar clusters are found at distance thresholds between 0.05% and 25%. All the considered phylogenies exhibit high tree imbalance with respect to what expected in random phylogenies, suggesting short infection times and antigenic drift, perhaps due to progressive transition from innate to adaptive immunity in the population.
Collapse
Affiliation(s)
- Mattia Prosperi
- Department of Epidemiology, College of Public Health and
Health Professions, University of Florida Gainesville, Fl,
USA
| | - Brittany Rife
- Department of Pathology, Immunology and Laboratory
Medicine, College of Medicine, University of Florida
Gainesville, Fl, USA
| | - Simone Marini
- Department of Epidemiology, College of Public Health and
Health Professions, University of Florida Gainesville, Fl,
USA
| | - Marco Salemi
- Department of Pathology, Immunology and Laboratory
Medicine, College of Medicine, University of Florida
Gainesville, Fl, USA
| |
Collapse
|
50
|
Dynamics of SARS-CoV-2 Variants of Concern in Vaccination Model City in the State of Sao Paulo, Brazil. Viruses 2022; 14:v14102148. [PMID: 36298703 PMCID: PMC9609010 DOI: 10.3390/v14102148] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2022] [Revised: 09/02/2022] [Accepted: 09/09/2022] [Indexed: 12/02/2022] Open
Abstract
From a country with one of the highest SARS-CoV-2 morbidity and mortality rates, Brazil has implemented one of the most successful vaccination programs. Brazil's first model city vaccination program was performed by the CoronaVac vaccine (Sinovac Biotech) in the town of Serrana, São Paulo State. To evaluate the vaccination effect on the SARS-CoV-2 molecular dynamics and clinical outcomes, we performed SARS-CoV-2 molecular surveillance on 4375 complete genomes obtained between June 2020 and April 2022 in this location. This study included the period between the initial SARS-CoV-2 introduction and during the vaccination process. We observed that the SARS-CoV-2 substitution dynamics in Serrana followed the viral molecular epidemiology in Brazil, including the initial identification of the ancestral lineages (B.1.1.28 and B.1.1.33) and epidemic waves of variants of concern (VOC) including the Gamma, Delta, and, more recently, Omicron. Most probably, as a result of the immunization campaign, the mortality during the Gamma and Delta VOC was significantly reduced compared to the rest of Brazil, which was also related to lower morbidity. Our phylogenetic analysis revealed the evolutionary history of the SARS-CoV-2 in this location and showed that multiple introduction events have occurred over time. The evaluation of the COVID-19 clinical outcome revealed that most cases were mild (88.9%, 98.1%, 99.1% to Gamma, Delta, and Omicron, respectively) regardless of the infecting VOC. In conclusion, we observed that vaccination was responsible for reducing the death toll rate and related COVID-19 morbidity, especially during the gamma and Delta VOC; however, it does not prevent the rapid substitution rate and morbidity of the Omicron VOC.
Collapse
|